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1. Introduction 
 
1.1 Phosphoinositide 3-kinases (PI3Ks) 
 
PI3Ks comprise a family of kinases that catalyse the transfer of the γ-phosphate group 
of ATP to the D3 position of phosphoinositides to generate PI(3)P, PI(3,4)P2, and 
PI(3,4,5)P3. This process can be repealed by the phosphatase and tensin homolog 
(PTEN) tumour suppressor protein or by Src-homology 2 (SH2) domain-containing 
inositol 5-phosphatase (SHIP) which dephosphorylate at the 3´-OH and 5´-OH 
position of the inositol ring, respectively. Since the discovery of a PI3K activity in 1988, 
eight PI3K catalytic subunits have been identified in mammals. Based on their 
different structure, substrate specificity and regulatory mechanisms, PI3Ks are divided 
into three main classes (Domin and Waterfield, 1997).  
 
1.1.1 Class I PI3Ks 
 
Class I PI3Ks are present in most cell types as heterodimeric proteins, consisting of a 
110-120 kDa catalytic subunit and an associated regulatory subunit. In vitro, they are 
able to phosphorylate PI, PI(4)P, and PI(4,5)P2, whereas in vivo their preferred substrate 
is PI(4,5)P2. Based on structural and functional differences, class I PI3Ks can be further 
divided into two subclasses, which signal downstream of receptor tyrosine kinase 
(RTK) and heterotrimeric G protein-coupled receptors (GPCR), respectively. 
 
Class IA PI3K 
 
Three isoforms of class IA PI3K have been found in mammals. They were cloned and 
designated PI3Kα (Hiles et al., 1992), PI3Kβ (Hu et al., 1993) and PI3Kδ 
(Vanhaesebroeck et al., 1997). PI3Kα and PI3Kβ are widely expressed in mammalian 
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tissues, while PI3Kδ is mainly expressed in leukocytes. All members are tightly and 
constitutively associated with a 50-85 kDa regulatory subunit. Based on the molecular 
weight, they have been named p85α, p85β, p55α, p55γ, or p50α (Katso et al., 2001).  
The catalytic subunit of class IA PI3K consists of four regions (Fig. 1): the N-terminal 
p85-binding domain, which binds to the regulatory subunit; the Ras-binding domain, 
which is unique to class I PI3K; the phosphoinositide kinase homology domain (PIK), 
which is conserved in all lipid kinases, and a C-terminal catalytic domain. 
 
Class IB
Class II
Class III
Class IA
p85α
p50
p55
p85β
SH3 P BH P N-SH2 C-SH2I-SH2
N-SH2 C-SH2P I-SH2
P N-SH2 C-SH2I-SH2
SH3 P BH P N-SH2 C-SH2 PI-SH2
P85-binding domain
Ras-binding domain
Catalytic domain
C2 domain 
PIK
BH:  Bcr homology 
domain
P: proline-rich motif
SH:  Src homology 
domain
 
 
Figure 1. Schematic diagram of catalytic and regulatory subunits of the 
heterodimeric phosphoinositide 3-kinases. 
 
 
The regulatory subunits do not possess any known enzymatic activity but are 
composed of several domains with homology to those found in other signalling 
proteins (Fig. 1). p85α and p85β contain an N-terminal Src-homology 3 (SH3) domain, 
a Bcr homology (BH) domain surrounded by two proline rich regions, and three SH2 
domains. The p50 and p55 adaptor proteins share the C-terminus of p85 and have a 
unique N-terminal sequence that lacks an SH3 motif, one proline rich region and the 
BH domain.  
In response to many cellular stimuli, the SH2 domains of the PI3K regulatory subunits 
bind selectively to the phosphorylated tyrosine residues of RTKs leading to the 
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translocation of the p110 catalytic subunit from the cytosol to the plasma membrane. 
This recruitment of p110 subunits is believed to be vital for PI3K activation. At the 
plasma membrane, activated class IA PI3Ks can readily access their lipid substrates, 
leading to a local increase in the production of PI(3,4,5)P3 which acts as a critical 
messenger in the regulation of several signalling pathways and different cellular 
functions, such as cell survival, proliferation and differentiation. In addition to lipid 
kinase activity, class IA PI3Ks exhibit an intrinsic protein kinase activity. The major 
substrates are serine residues within the catalytic subunit itself or its associated 
regulatory subunit. For instance, p110α was able to phosphorylate its regulatory 
subunit p85α at serine 608 (Yu et al., 1998). In contrast, p110β and p110δ did not 
phosphorylate their adaptor molecules but express the capability to autophos- 
phorylate serine 1070 of p110β (Czupalla et al., 2003) or serine 1039 of p110δ 
(Vanhaesebroeck et al., 1999a), respectively. Interestingly, the p110α-mediated p85 
phosphorylation or p110δ autophosphorylation led to diminished lipid kinase activity of 
the enzymes, while autophosphorylation of p110β did not alter its lipid kinase activity 
(Czupalla et al., 2003; Vanhaesebroeck et al., 1999a). 
Additionally, it should be mentioned that not only tyrosine kinases, but also Gβγ 
heterodimers express the ability to activate p110β. It has been shown that the activity 
of p85/p110β was stimulated by G protein βγ subunits in cell-free systems (Hazeki et 
al. 1998). Moreover, Murga et al. have shown that p110β was required to stimulate 
Akt through a GPCR pathway in murine fibroblasts in vivo (Murga et al., 2000). 
Similarly, in bovine aortic endothelial cells (BAEC), sphingosine 1-phosphate (S1P) 
stimulation resulted in a rapid and isoform-specific activation of p110β in a 
Gβγ-dependent manner (Igarashi and Michel, 2001b) 
 
Class IB PI3K 
 
The unique member of class IB PI3K identified to date is the p110γ catalytic subunit 
with 36 % identity to p110α. The first indication for this isoform were observed in 
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neutrophils stimulated with a formulated tripeptide, formyl-methionine-leucine- 
phenylalanine (fMLP), which led to a rapid increase in PI(3,4,5)P3 levels (Stephens et al., 
1993). Screening a human bone marrow cDNA library, Stoyanov et al. subsequently 
cloned and characterised a novel PI3K isoform, PI3Kγ, which associates with and is 
activated by Gi protein βγ subunits (Stoyanov, 1995). PI3Kγ was initially believed to be 
mainly expressed in haematopoietic cells. However, recent studies provided evidence 
for a wider expression pattern of PI3Kγ in other tissues like smooth muscle, kidney 
and heart. The broad distribution of PI3Kγ illustrates its importance in the regulation of 
diverse cell functions. 
The three dimensional structure of PI3Kγ has been determined (Walker et al., 1999) 
(Fig. 1). The catalytic subunit is composed of a C-terminal catalytic domain, a C2 
domain, a PIK domain, a Ras binding domain (RBD), and an N-terminal region, which 
shares some similarity to the Pleckstrin homology (PH) domain of Rho-GAP 
(GTPase-activating proteins) and was previously proposed to be important for the 
interaction with the regulatory subunit (Krugmann et al., 1997). Different from 
members of PI3K class IA, PI3Kγ was found in association with a novel 101 kDa 
adaptor protein, p101 (Stephens et al., 1997). In addition, a new adaptor protein of 
PI3Kγ, p87PIKAP(PI3Kγ adaptor protein) (p87, also termed p84), has been identified with a 
homologous region to p101 within the p110γ and Gβγ-interacting domains (Voigt et al., 
2006; Suiro et al., 2005). Its gene locates next to the p101 locus and exists in many 
mammals. In a monkey SV40-transformed kidney fibroblast cell line (COS-7) and a 
human embryonic kidney epithelial cell line (HEK293), p101 is predominantly 
distributed within the nucleus in the absence of p110γ, and translocated to the cytosol 
when p110γ is coexpressed. On the contrary, p87 is present in the cytosol regardless 
of the existence of p110γ (Voigt et al., 2006). Both adaptors bind to the p110γ catalytic 
subunit with a comparable affinity (Surie et al., 2005) whereas the affinity of Gβγ 
binding seems to be higher for p101 compared to p87 (Surie et al. 2005). However, 
the association of p87 with Gβγ could not be detected by another group (Voigt et al., 
2006).  
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Despite being termed adaptor/regulatory subunits, the functional relevance of the 
p101 and p87 to date is limited. It has been demonstrated that coexpression of 
p110γ/p101 in the insect cell line Sf9 and in COS-7 cells resulted in a significant 
increase in PI(3,4)P2 and PI(3,4,5)P3 production as compared to the expression of p110γ 
alone. In agreement, fMLP-induced increase of PI(3,4,5)P3 generation and PI3Kγ 
activation were dependent on the expression of either p101 or p87 (Stephens et al., 
1997; Voigt et al., 2006). Additional finding proposed that p101 is responsible for the 
PI(4,5)P2 substrate selectivity of p110γ, by sensitizing p110γ towards Gβγ in the 
presence of PI(4,5)P2 (Maier et al., 1999). However, several reports demonstrated that 
p110γ can associate with Gβγ directly and that p110γ lipid kinase activity was 
substantially activated by Gβγ even in the absence of p101 subunit (Stoyanov et al., 
1995; Tang and Downes, 1997; Leopoldt et al., 1998), arguing against an 
indispensable role of p101 in Gβγ stimulation of p110γ. 
The PI3Kγ activation can be induced by many agonists through GPCR, such as 
monocyte chemoattractant protein (MCP-1), stromal-cell derived factor 1 (SDF-1), 
fMLP, and interleukin-8 (IL-8). In response to stimulation, PI3Kγ displays not only lipid 
kinase activity, but also protein kinase activity. Utilizing PI3Kγ mutants with aborted 
lipid kinase activity, Bondeva et al. demonstrated that MAPK was activated in the 
complete absence of PI(3,4)P2 and PI(3,4,5)P3 production (Bondeva et al., 1998). Based 
on these findings, the authors suggested that PI3Kγ is capable of activating two 
distinct pathways: the lipid kinase activity of PI3Kγ is responsible for 3-phosphorylated 
lipid production while the PI3Kγ protein kinase activity contributes to MAPK stimulation 
and propagation of growth signals. Moreover, recombinant PI3Kγ has been indicated 
to catalyse transphosphorylation of the adapter protein p101 and the protein kinase 
MEK-1, which was completely abolished by the PI3K inhibitor wortmannin (Bondev et 
al., 1999). Czupalla et al. showed that PI3Kγ was also able to autophosphorylate the 
p110γ catalytic subunit at serine 1101 residue, which was also stimulated by Gβγ 
subunits in a time- and concentration-dependent manner. Interestingly, the autophos- 
phorylation of PI3Kγ had no inhibitory effect on its lipid kinase activity (Czupalla et al., 
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2003).  
Due to the relatively recent discovery of PI3Kγ, the functional significance of PI3Kγ is 
only preliminarily determined. To investigate the role of PI3Kγ in biological responses, 
mice lacking p110γ have been generated. The absence of PI3Kγ in mice led to an 
increased population of neutrophils, monocytes and eosinophils. In contrast, the 
proliferation and activation of thymocytes were reduced (Sasaki et al., 2000). In 
response to chemoattractants such as fMLP, complement factor 5a (C5a) and IL-8, 
the production of PI(3,4,5)P3 as well as the phosphorylation of ERK and Akt were 
abolished in PI3Kγ-/- neutrophils. Accordingly, fMLP- and C5a-stimulated neutrophil 
migration and respiratory burst were remarkably reduced in cells lacking p110γ 
(Sasaki et al., 2000; Li et al., 2000; Hirsch et al., 2000; Hannigan et al., 2002). The 
role of PI3Kγ has also been investigated in bone marrow-derived mast cells (BMMC). 
Mast cells are key players in allergy and inflammation. In PI3Kγ-deficient BMMCs, 
PI(3,4,5)P3 production as well as PI(3,4,5)P3-dependent Akt phosphorylation were 
impaired in response to adenosine, a GPCR agonist, whereas no alteration was 
observed in both events upon challenge with agonists coupled to RTK (e.g. IL-3, stem 
cell factor-1). These results confirm that p110γ is activated by G-protein coupled 
receptors but not by RTKs. 
To date, the investigations of the role of PI3Kγ were mainly performed in 
haematopoietic cells. Although the expression of this protein has also been observed 
in endothelial cells very recently, the function of PI3Kγ in this cell type is poorly 
characterised. 
 
1.1.2 Class II and III PI3Ks  
 
Members of class II PI3Ks are approximately 170-210 kDa, containing three groups, 
PI3K II α, β and γ. They are composed of a C-terminal C2 domain, which has been 
implicated to bind to phospholipids in vitro (MacDougall et al. 1995) and an N-terminal 
region that contains a Ras binding domain. In vitro, Class II PI3K can be activated by 
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growth factors, integrins and chemokines. Upon activation, these enzymes 
phosphor-rylate PI and PI(4)P to produce PI(3)P and PI(3,4)P2 with a strong preference 
for PI.  
A well-known class III PI3Ks isoform is the Saccharomyces cerevisiae VPS34 
(vesicular-protein-sorting) gene product, Vps34p (Schu et al., 1993). It has been 
shown in association with a Vps15p protein serine/threonine kinase in yeast (p150 in 
mammals), which is essential for the recruitment of Vps34p to the Golgi membranes 
and activation of its lipid kinase activity. In vitro, class III PI3Ks utilise PI as a substrate 
and are likely to be responsible for the production of most of the PI(3)P in cells. 
 
 
1.2 Signalling reactions of PI3-kinases  
 
A number of proteins have been identified that directly bind to PI(3,4)P2 and PI(3,4,5)P3 
via their PH domain, such as protein kinases (Akt/protein kinase B (PKB), 
phosphoinositide-dependent protein kinase 1 (PDK1) and Bruton's tyrosine kinase 
(Btk)), guanine nucleotide exchange factors (GEFs) such as Vav and Sos1, 
GTPase-activating factors (GAP1), phospholipases (PLCγ2, PLCδ1), and adaptor 
proteins. 
 
1.2.1 Akt/PKB  
 
Akt, also termed PKB, is one of the best characterised downstream effectors of PI3Ks. 
It was cloned in 1991 as a cellular homologue of the retroviral oncogene v-akt 
(Bellacosa et al., 1991; Coffer & Woodgett, 1991; Jones et al., 1991), and consists of 
an N-terminal PH domain, a kinase domain and a C-terminal regulatory region. The 
binding of the PH domain to PI(3,4,5)P3 recruits Akt from the cytosol to the plasma 
membrane, where it can be activated via phosphorylation of threonine 308 and serine 
473 (Alessi et al., 1996).  
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Activated Akt mediates several biological events via different downstream substrates. 
For instance, Akt was able to directly phosphorylate mTOR/FRAP, then leading to the 
phosphorylation of eIF-4E binding protein (4E-BP) and activating mRNA translation 
(Gingeras et al., 1999). Furthermore, Akt is responsible for regulation of cell apoptosis. 
p70 S6 kinase (p70S6K), an anti-apoptotic effector, has been demonstrated to be 
directly activated by Akt (Zhang et al., 2005) and negatively regulates BAD 
(Bcl-xL/Bcl-2-associated death promoter)-induced apoptosis (Harada et al., 2001). 
Moreover, BAD is also a downstream target of Akt, which is directedly phosphorylated 
by Akt and thus, inhibites cell apoptosis by releasing the anti-apoptotic proteins Bcl-XL 
and Bcl-2 (Datta et al., 1997). Alternatively, Akt has also been known as a promoter of 
cell survival. Direct phosphorylation of glycogen synthesis kinase-3 (GSK-3) by Akt 
led to a decrease in GSK-3 activity inhibiting glycogen synthesis and mediating 
endothelial cell survival (Kandel and Hay, 1999; Kim et al., 2002; Skurk et al., 
2005). Important stimuli of Akt, including vascular endothelial growth factor (VEGF) 
and S1P, activate Akt through PI3K, thereby promoting cell survival (Alon et al., 1995; 
Igarashi et al., 2001a).  
Former studies have revealed a role of Akt in cell migration. Interestingly, more recent 
studies suggest that Akt may play both negative and positive roles in the regulation of 
cell migration in an isoform-specific manner. Irie et al. have shown that Akt1 
downregulated migration in epithelial cells (Irie et al., 2005) and breast cancer cells 
while Akt2 functioned as a positive regulator (Yoeli-Lerner et al., 2005; Wyszomierski 
et al., 2005). In contrast, in response to PDGF, the Akt1 deficiency reduced migration 
of mouse embryo fibroblasts, whereas Akt2 deficiency increased the cell movement 
by increasing the activities of the small GTPase Rac and p21 activated kinase 1 
(PAK1) (Zhou et al., 2006). Similarly, Akt positively regulates migration of endothelial 
cells which predominantly express Akt1 (Chen et al., 2005). In these cells, Akt 
activation and the subsequent migration were not only induced by various growth 
factors, but also by bioactive lysophospholipids, in particular by S1P (see below). One 
downstream target involved in this process is endothelial nitric oxide synthase (eNOS) 
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which is phosphorylated by Akt and seems to be required for directional cell 
movement in response to VEGF (Morales-Ruiz et al., 2001). Coordinately, Ackah et al. 
has indicated that Akt1 is importance for endothelial cell migration via stimulating nitric 
oxide (NO) production (Ackah et al., 2005). Additionally, important downstream 
substrates of Akt in the regulation of cell migration appear to be Rho family GTPases, 
although several groups have suggested that the small GTPase Rac may also be 
upstream of Akt phosphorylation (Lee et al., 2001; Gonzalez et al., 2006). However, 
the mechanism of this process seems to be complex and needs more clarification.  
 
1.2.2 Rho GTPases  
 
The Rho GTPase family belongs to the Ras superfamily of monomeric 20-30 kDa 
GTP-binding proteins, sharing approximately 25 % sequence identity to Ras. To date, 
21 members have been discovered in mammals. Based on their primary sequence 
and function, they can be divided into five subgroups: Rho-like, Rac-like, Cdc42-like, 
Rnd and RhoBTB (Burridge et al., 2004). These proteins cycle between inactive 
GDP-bound state and active GTP-bound state. In the active state, they are able to 
interact with downstream effectors and transmit signals. Binding of targets terminates 
responses by hydrolysis of the protein-bound GTP. The interconversion between 
inactive and active states is regulated by three types of proteins: GTPase-activating 
proteins (GAP), which stimulate intrinsic GTPase activity; guanine nucleotide 
dissociation inhibitors (GDI), which inhibit the exchange of GDP for GTP, and guanine 
nucleotide exchange factors (GEF), which catalyse the exchange of GDP for GTP and 
therefore induce the accumulation of the active GTP-bound form. Several GEFs are 
known to be downstream mediators of Class I PI3Ks.  
Three members, Rho, Rac, and Cdc42, have been well characterised during the last 
few years. They have been shown to contribute to the regulation of several cell 
responses such as enzyme activation, cell polarity, gene transcription, cell cycle 
progression and survival (Hall, 2005). Moreover, they were characterised as key 
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regulators being responsible for the rearrangement of actin cytoskeleton and the 
promotion of cell motility by different mechanisms (Fig. 2). Rho was shown to 
regulate stress fibers formation, focal adhesion and cell contraction, whereas Rac 
and Cdc42 stimulate lamellipodia/ruffles production and filopodia formation, 
respectively (Ridley and Hall, 1992; Nobes and Hall, 1995).  
Although Rho and Rac have been shown to mediate cell migration in a coordinated 
manner, more recent studies focused on the influence of Rac in promoting cell 
chemotaxis. Activation of Rac1 was found to be necessary for cell migration in 
different cell types including glioma cells, neutrophils, smooth muscle and endothelial 
cells (Malchinkhuu et al., 2005; Pestonjamasp et al., 2006; Goueffic et al., 2006). 
Several studies have demonstrated that Rac activation occurs via pathways involving 
PI3K and/or Akt. For instance, chemokine-stimulated Rac activation via a Gi 
protein/PI3K pathway was critical for macrophage migration (Weiss-Haljiti et al., 2004) 
and in embryo fibroblasts active Rac1 mediates cell migration in an Akt-dependent 
manner (Zhou et al., 2006; Qian et al., 2004). In endothelial cells, S1P stimulated Rac 
in a S1P1/PI3K/Akt-dependent manner, involving the phosphorylation of S1P1 by the 
Akt activation (Lee et al., 2001). Furthermore, the migration was increased in cells 
coexpressing a GEF, P-Rex2b, with Gβγ and/or PI3K (Li et al., 2005). Recently, it 
became apparent that a downstream effector of Rac, cortactin, was involved in 
Rac-dependent cytoskeleton remodeling. Upon the cell stimulation, cortactin 
translocates to actin polymerisation sites on plasma membrane, thus regulating actin 
rearrangement and cell migration. This response was inhibited by expression of a 
dominant negative Rac mutant in the cells (Vouret-Craviari et al., 2002). The 
interaction of Cortactin with Arp2/3 (Lee et al., 2006a) or with zonula occludens-1, a 
tight junction associated protein (Lee et al., 2006b) was involved in this process. 
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Figure 2. Distinct roles of Rho family small GTPases in regulating cell 
migration (from position A to B). In response to a chemoattractant gradient, 
migrating cell extends lamellipodia/filopodia at the leading edge. The response 
is dependent on the activation of Rac/Cdc42, which subsequently promotes 
localised actin polymerisation. Furthermore, the cell body follows the front of the 
cell and the trailing edge retracts via enhanced actomyosin contractility which is 
manifested by Rho-dependent stress fiber formation. (Adapted from Fenteany 
and Zhu, 2003) 
 
 
Taken together, these findings indicate the essential role of PI3K/Rac signalling 
pathway in the regulation of cell motility. However, the mechanism of PI3K-regulated 
Rac activity and the involved signalling molecules are not well characterised. 
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1.3 Cell migration and endothelium  
 
The endothelium is the monolayer of endothelial cells lining the lumen of blood 
vessels. The structure and functional integrity of endothelial cell are important in the 
maintenance of the vessel wall and circulatory function. Moreover, the endothelium is 
responsible for the regulation of vascular tone, blood flow, metabolic, synthetic, 
anti-inflammatory and antithromobogenic processes as well as for angiogenic 
vascular remodeling (Galley et al., 2004), and is indispensable for body homeostasis. 
Accordingly, an uncontrolled endothelial response is involved in many disease 
processes, including atherosclerosis, hypertension and inflammatory syndromes. 
A major function of endothelial cells is the regulation of angiogenesis, which is defined 
as the process by which new blood vessels are formed from the pre-existing 
vasculature. Under physiological conditions, angiogenesis is tightly regulated and 
plays an essential role in development, reproduction, inflammation and wound healing. 
However, unregulated angiogenesis can occur under pathological conditions and 
contributes to numerous diseases, including tumour growth, diabetic retinopathy and 
rheumatoid arthritis. Angiogenesis involves several major processes such as 
increased permeability, degradation of the extracellular matrix by proteolytic enzymes, 
migration and proliferation of endothelial cells, and morphological differentiation into 
three dimensional tubular structures (Carmeliet et al., 2003). Thus, to achieve new 
blood vessel formation, endothelial cells escape from their stable location by breaking 
through the basement membrane and migrate toward an angiogenic stimulus 
released from adjacent tumour cells, activated blood cells, or wound-associated 
macrophages. Behind this migrating front, endothelial cells proliferate and finally, the 
new outgrowth of endothelial cells reorganises into capillaries which are stabilised by 
the formation of a new basement membrane and the recruitment of pericytes. 
Dysregulation of angiogenesis can result in insufficient vascularisation or in the 
formation of immature vessels (Carmeliet et al., 2003). On the other hand, 
uncontrolled angiogenesis supports tumour progression. Angiogenesis is controlled 
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by a balance between stimulatory and inhibitory factors. Growth factors, in particular 
VEGF, are essential for most steps in angiogenesis. Recently, however, other 
mediators such as S1P that accumulates at high levels at sites of vascular injury have 
been observed to potently contribute to angiogenesis (see below) (Ancellin et al., 
2002). 
In order to target unwarranted angiogenesis or to be able to stimulate angiogenesis in 
ischemic tissues, the underlying mechanisms including signalling pathways regulating 
cell migration need to be fully clarified. Endothelial cell migration is a critical event in 
angiogenesis which is triggered by several agonists including VEGF, fibroblast growth 
factor (FGF), integrins and as discussed below, S1P. Cell migration involves sensing 
of a chemokine, organisation of signalling asymmetry, cytoskeleton reorganisation 
with localised actin polymerisation at the leading edge, new cell adhesion at the front 
of the cell and contraction of the body and rear of the cell. The signalling molecules 
regulating endothelial migration have, at least in part, been introduced in the 
preceeding paragraphs and involve PI3Ks, Akt, eNOS and Rac1. Importantly, 
although the role of PI3K isoforms in neutrophil migration has been intensively 
investigated, their function in endothelial migration is hardly known. For instance, 
polarised PI3Kγ activity and PI(3,4,5)P3 production are thought to organise the leading 
edge of leukocytes by, at least in part, asymmetrical recruitment of Rho GTPases 
which are involved in actin reorganisation (Rickert et al. 2000). Similar processes may 
occur in endothelial cells and the contribution of different PI3K isoforms may be 
stimulus-dependent and may involve synergistic as well as specific reactions. The 
clarification of these signalling pathways will lead to a better understanding of 
endothelial migration and finally, angiogenesis. 
 
 
1.4 Sphingosine 1-Phosphate (S1P)  
 
S1P is a polar lysophospholipid metabolite that has been proposed to act as an 
extracellular mediator and an intracellular second messenger. Platelets which are rich 
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source of S1P release it upon activation by prothrombotic stimuli such as thrombin, 
ADP, and collagen. S1P is also synthesised in a wide variety of other cell types in 
response to extracellular stimuli such as growth factors and cytokines. The 
concentration of S1P in serum is about 0.5 µM, which is considerably higher than in 
plasma (0.1 µM). The biosynthesis of S1P has been well characterised and starts with 
the breakdown of a number of membrane phospholipids to produce sphingomyelin 
that is cleaved by sphingomyelinase and ceramidase to generate sphingosine (Fig. 3). 
Furthermore, sphingosine kinase catalyzes the phosphorylation of sphingosine to 
sphingosine 1-phosphate. Conversely, S1P can either be degraded via dephospho- 
rylation by S1P phosphatase back to sphingosine or cleaved by S1P lyase to produce 
hexadecanal and phosphoethanolamine.  
S1P regulates various biological functions in many vertebrate cell types, including 
proliferation, migration, apoptosis, cytoskeletal organisation and differentiation. 
Therefore, S1P has been implicated in many physiological processes and 
pathophysiological states, such as wound healing, inflammation, cancer and tumour 
angiogenesis. Most effects are mediated via signalling pathways activated by binding 
of S1P to its receptors.  
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Figure 3. S1P synthesis and degradation  
(Adapted from Alewijnse et al. 2004) 
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1.4.1 S1P receptors 
 
The receptors of S1P were cloned and characterised as a family of GPCR, previously 
known as endothelial differentiation genes (Edg), which can be divided into two 
subgroups based on ligand specificity. One group exhibits high affinity for 
lysophosphatidic acid (LPA) and consists of three members: Edg-2, Edg-4, Edg-7 
(also known as LPA-1, LPA-2, and LPA-3). The second subgroup comprises five 
isoforms which display high affinity for S1P: Edg-1, Edg-3, Edg-5, Edg-6 and Edg-8, 
which have been recently renamed as S1P1, S1P3, S1P2, S1P4, and S1P5, 
respectively.  
 
S1P1 (Edg-1) 
 
S1P1, the first member of S1P receptors, was originally cloned and characterised as 
an immediate-early gene product in phorbol ester-differentiated human umbilical vein 
endothelial cells (HUVEC) (Hla et.al., 1990). It is a protein composed of 380 amino 
acids with seven hydrophobic, transmembrane spanning domains and it binds to S1P 
with a high affinity (Kd 8-20 nM). Following S1P stimulation, S1P1 associates with the 
pertussis toxin (PTX)-sensitive heterotrimeric Gi/O-protein with high affinity. 
Additionally, Lee et al. suggested that S1P1 phosphorylation catalysed by its 
downstream effector Akt is indispensable for S1P-induced signalling pathways (Lee 
MJ. et al., 1999). 
S1P1 is widely expressed in different tissues and cell types, such as immune, 
neuronal, smooth muscle and endothelial cells, suggesting its importance in 
regulating different physiological and pathological responses. In endothelial cells, 
many cellular effects of S1P have been proposed to be mediated by S1P1 activation.  
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S1P3 (Edg-3) 
 
Expression of S1P3 is also detected in endothelial cells. It was initially cloned from a 
human genomic library during a search for human cannabinoid receptors. Different 
from S1P1, it is expressed in HUVEC at lower level (Wang et al., 1999a) and interacts 
not only with heterotrimeric Gi proteins, but also with Gq, G12 and G13. S1P3 exhibits a 
wide tissue expression pattern, with highest levels in endothelial cells, leukocytes and 
cardiovascular tissue. Surprisingly, deletion of S1P3 in mice results in no visual 
phenotypic abnormality, indicating that other receptors may be able to compensate for 
S1P3 function.  
 
1.4.2 S1P-mediated cellular responses in endothelial cells 
 
Recent studies have focused on the molecular mechanisms of receptor-mediated 
responses to extracellular S1P in endothelial cells. According to these studies S1P is 
thought to be an important angiogenic mediator regulating different endothelial cell 
responses. For instance, S1P has been shown to induce proliferation in HUVEC (Lee 
MJ. et al., 1999; Lee et al., 2000). This response was inhibited by treatment of cells 
with a Gi/o protein-specific inhibitor, PTX (Kimura et al., 2000), suggesting the 
involvement of a S1P1/Gi signalling pathway. S1P also promotes endothelial tube 
formation in vitro in a Gi-dependent way (Wang et al., 1999a; Lee OH. et al. 1999). 
Deletion of S1P1 in mice resulted in embryonic lethality due to the incomplete 
maturation of blood vessels (Lee PC. et al., 1999; Liu et al., 2000). More recently, 
Thompson et al. have observed an essential role of S1P3 in Ca2+-dependent 
morphogenesis of endothelial cells in response to S1P (Thompson et al., 2006). 
Importantly, the role of S1P in the regulation of endothelial cell motility has been 
observed. Generally, S1P has been shown to regulate migration in both negative and 
positive ways. An inhibited migration by S1P has been shown in human breast cancer 
cells, myoblasts and vascular smooth muscle cells (VSMC, Wang et al., 1999b; 
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Becciolini et al., 2006; Ryu et al., 2002), whereas stimulation of migration by S1P has 
been found in fibroblasts, VSMC (Long et al., 2006; Kluk and Hla, 2001) and in 
endothelial cells.  
Several groups have demonstrated that S1P stimulates migration of endothelial cells 
in a concentration-dependent manner (Panetti et al., 2000; Kimura et al. 2000; Lee et 
al., 2000). Therefore, the signalling pathways underlying S1P-induced migration have 
been partially revealed (Fig. 4). For example, S1P-stimulated migration is diminished 
in S1P1 null cells (Liu et al., 2000). Accordingly, cells expressing a mutant of S1P1, 
T236AEDG-1 which is unable to be phosphorylated, show reduced migration 
indicating the importance of S1P1 in this process (Lee et al., 2001). Moreover, 
S1P-induced migration was decreased by pretreatment with PTX or with the PI3K 
inhibitors wortmannin and LY294002 (Kimura et al., 2000; Lee et al., 2000), 
implicating the involvement of a GPCR/Gi/PI3K pathway in S1P-induced endothelial 
cell migration. It has also been suggested that S1P-dependent transactivation of 
VEGF receptors via S1P1 and Gi protein leads to activation of Src, and the adaptor 
protein CrkII is responsible for both the induction of membrane ruffling and the 
increase in cell motility. Accordingly, the inhibition of the VEGF receptor abolished 
S1P-induced migration (Endo et al., 2002). Interestingly, VEGF was also able to 
enhance S1P1 expression (Igarashi et al., 2003; Hughes et al., 2005). These data 
represent examples for the crosstalk between S1P1 and RTK signalling pathways.  
Akt and small GTPases have been identified as downstream effectors of S1P. Upon 
stimulation with S1P, PI3Ks lead to the activation of protein kinase Akt which in turn 
phosphorylates eNOS. Furthermore, Akt also mediates the phosphorylation of S1P1, 
that seems to be essential for the activation of the small GTPase Rac which is 
involved in cytoskeleton reorganisation and cell migration (Rishiyuki et al., 2002; lee 
et al., 2001; Panetti et al., 2000). S1P3 is also able to mediate Rac activation in a Gi 
protein-dependent manner and in addition, it can induce the activation of another 
small GTPase, RhoA, which regulates actin-myosin interactions necessary for cell 
motility (Ohmori et al., 2001; Inoki et al., 2006).  
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Figure 4. S1P-induced signalling pathways of endothelial cell migration  
 
 
Taken together, S1P is an important stimulus for many cellular responses, particularly 
for cell motility. PI3Ks, activated through Gi protein- or tyrosine kinase-dependent 
signalling pathways, appear to be critical players in S1P-iniated cell migration. Thus, it 
will be interesting to analyse the regulatory function of PI3Ks in S1P-induced 
endothelial cell motility.  
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1.5 Project aim  
 
As described above, PI3Ks, in particular class I, are important enzymes that regulate 
cell migration in response to different stimuli in neutrophils, monocytes and other cell 
types. Two isoforms of class I, PI3Kβ and PI3Kγ, have been indicated to be activated 
by Gi proteins. However, the function of these two isoforms in endothelial cells is not 
well characterised. Platelet-derived S1P has been demonstrated to mediate PI3K 
activity via the activation of its Gi protein coupled receptor S1P1 in endothelial cells. It 
has been demonstrated that this signalling pathway mediates endothelial cell 
migration which is an essential step in the process of angiogenesis. However, to date, 
the mechanisms of S1P-induced endothelial cell migration, especially the contribution 
of PI3Kβ and PI3Kγ, are not fully understood. Moreover, it is not known whether these 
isoforms act via distinct signalling pathways. 
The aim of the present study was to investigate the role of PI3Kβ and/or PI3Kγ in 
S1P-induced endothelial cells migration. We detected the protein expression of these 
two isoforms in human and mouse vascular endothelial cells. Their role in regulating 
the downstream signalling pathways and endothelial cell motility was studied using 
different PI3Kβ or PI3Kγ isoform-specific tools such as inhibitors, cDNA plasmids and 
gene knockout murine cells.   
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2. Materials and Methods 
 
2.1 Materials 
 
2.1.1 Animals  
 
p110γ-/- mice, a kind gift from the Dipartimento di Genetica, Biologia e Biochimica, 
Universita di Torino, Italy, were generated as described before (Hirsch et al., 2000). 
Both wild-type and p110γ-/- animals were bred and housed in the Institute of 
Laboratory Animal Science of the FSU Jena. About 10-12 week-old littermates from 
heterozygous crosses were used in the current study. 
 
2.1.2 Primary cells culture 
 
• HUVEC , Human Umbilical Vein Endothelial Cells 
• MLEC, Murine Lung Endothelial Cells  
(Preparation see 2.2) 
 
2.1.3 Plasmids 
 
• pcDNA3, mammalian expression vector (Invitrogen, GmbH, Karlsruhe) 
• pcDNA3-PI3Kγ KR, kinase dead mutant of PI3Kγ; Lys833 to Arg mutation in 
catalytic domain  
• pcDNA3-PI3Kβ  KR , kinase dead mutant of PI3Kβ; Lys805 to Arg mutation in 
catalytic domain  
 
2.1.4 Antibodies 
 
• Anti-PI3Kγ monoclonal antibody, directed against the N-terminal fragment of 
PI3Kγ (provided by the Institute of Molecular Cell Biology, University of Jena) 
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• Anti-PI3Kβ polyclonal antibody (Santa Cruz Biotechnology, Heidelberg) 
• Anti-phospho-ERK monoclonal antibody (New England Biolabs, Frankfurt) 
• Anti-pan-ERK monoclonal antibody (BD Transduction Laboratories, Heidelberg) 
• Anti-phospho-Akt polyclonal antibody, serine 473 (Cell Signalling Technology, 
Frankfurt) 
• Anti-Akt1 monoclonal antibody (Santa Cruz Biotechnology, Heidelberg) 
• Anti-phospho-eNOS polyclonal antibody, serine 1177 (Cell Signalling Technology, 
Frankfurt) 
• Anti-eNOS polyclonal antibody (BD Transduction Laboratories, Heidelberg) 
• Anti-Rac1 monoclonal antibody (BD Transduction Laboratories, Heidelberg) 
• Anti-vinculin monoclonal antibody (Cell Signalling Technology, Frankfurt) 
• Peroxidase conjugated goat anti-mouse IgG (Kirkegaard & Perry Laboratories, 
USA) 
• Peroxidase conjugated goat anti-rabbit IgG (Kirkegaard & Perry Laboratories, 
USA) 
• Rat anti-mouse CD102 antibody (BD Bioscience, Heidelberg) 
 
2.1.5 Oligonucleotides  
 
Oligonucleotides for human p101-specific RT-PCR 
Forward Primer 5’- CTGGGCTGTGTCTGAACTG -3’ 
Reverse Primer 5’- GTGGTGTAGGCACTGTGAG -3’ 
 
Oligonucleotides for murine p101-specific RT-PCR 
Forward Primer 5’- CTGGGCAGAAGTTCAACAG -3’ 
Reverse Primer 5’- AGAAGCGTGTGAGGATAGG -3’ 
 
Oligonucleotides for human p87-specific RT-PCR 
Forward Primer 5’- TGGTCATTGCCGAACAGAAC -3’ 
Reverse Primer 5’- TCAGTGGACAGCACAGAAAC -3’ 
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Oligonucleotides for murine p87-specific RT-PCR 
Forward Primer 5’- CTGGAGAAGGCAGAAAGC -3’ 
Reverse Primer 5’- AGGCGACTGTAGAGTAGG -3’ 
 
2.1.6 Inhibitors 
 
• Pertussis toxin (ALEXIS, Grünberg) 
• LY294002 (Calbiochem, Schwalbach) 
• Wortmannin (Sigma Chemical CO., Deisenhofen) 
• TGX-221 (Australian Centre for Blood Diseases, Monash University, AMREP, 
Melbourne, Victoria, Australia) 
• AS-252424 (Australian Centre for Blood Diseases, Monash University, AMREP, 
Melbourne, Victoria, Australia) 
• Phenylmethylsulfonylfluoride (PMSF, Sigma Chemical CO., Deisenhofen) 
• Protease inhibitor cocktail (PIC) (Roche, Basel, Switzerland) 
• Nitro-L-arginine methyl ester (L-NAME), (ALEXIS, Grünberg)  
 
2.1.7 Cell preparation and culture reagents 
 
• Dulbecco’s modified Eagle medium (DMEM) (Life Technologies GmbH, 
Eggenstein) 
• DMEM/F-12 (PAA Laboratories GmbH, Pasching, Austria) 
• Medium 199 (M199), (Cambrex Bio Science, Verviers SPRL, Belgium) 
• Fetal calf serum “heat inactivated” (FCS) (Cambrex Bio Science, Verviers SPRL, 
Belgium) 
• Human serum “heat inactivated” (Cambrex Bio Science, Verviers SPRL, Belgium) 
• Endothelial cell growth supplement (ECGS), (Sigma Chemical CO., Deisenhofen) 
• Endothelial mitogen (Biomedical Technologies, Stoughton, USA) 
• Heparin-sodium (Roche, Basel, Switzerland) 
• Heparin (Sigma Chemical CO., Deisenhofen) 
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• L-Glutamine (ICN Biomedicals, Eschwege)  
• Penicillin/Streptomycin (Gibco BRL, Eggenstein) 
• Collagenase II (Worthington Biochemical Corporation, Lakewood, USA) 
• Trypsin-EDTA (Sigma Chemical CO., Deisenhofen ) 
• Gelatin (ICN Biomedicals, Eschwege) 
• M-450 sheep anti-rat beads (Dynal Biotech, Hamburg) 
 
2.1.8 Other reagents and materials 
 
• Triton X-100 (Carl Roth GmbH & Co KG, Karlsruhe) 
• Tween 20 (Serva, Heidelberg) 
• Dimethyl sulfoxide (DMSO), (Sigma Chemical CO., Deisenhofen)  
• D-Erythro sphingosine 1-phosphate (S1P) (Biomol, Plymouth) 
• Bovine serum albumin (BSA, Carl Roth, Karlsruhe) 
• Human serum albumin (HSA, Bayer Vital, Leverkusen)  
• Prestained protein marker (New England Biolabs, Frankfurt) 
• 100bp smart ladder (Eurogentec, Seraing, Belgium) 
• ECLTM Western blotting detection reagents (GE Healthcare Lifescience, 
Buckinghamshire, United Kingdom) 
• Hematoxylin (Dako, Hamburg) 
• Eukitt mounting medium (Merck, Darmstadt) 
• Glutathione-sepharose 4B (Amersham Pharmacia, Uppsala, Sweden) 
• Protein A-sepharose (Amersham Pharmacia, Uppsala, Sweden) 
• Trizol reagent (Invitrogen GmbH, Karlsruhe) 
• Isopropanol (Sigma Chemical CO., Deisenhofen)  
• Chloroform (Sigma Chemical CO., Deisenhofen) 
• Qiagen one-step RT-PCR kit (Qiagen, Düsseldorf) 
• Magnetic particle concentrator (MPC) magnet (Dynal Biotech, Hamburg) 
• Mesh (100 μm) (BD Bioscience, Heidelberg) 
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• Falcon cell culture inserts (0.8 μm)/Companion Plates (BD Bioscience, 
Heidelberg) 
• 0.45  μm Filtropur filtration unit (Sarstedt, Nuembrecht) 
• Hoefer electrophoresis chamber (Hoefer Scientific, San Francisco) 
• Whatman 3MM paper (Whatman GmbH, Dassel) 
• Immobilon polyvinyldifluoride (PVDF) membrane (Millipore Corporation, Bedford, 
USA) 
• BioMax MR-1 film (Eastman Kodak Company New Haven, USA) 
• HUVEC nucleofector kit (Amaxa, Koeln) 
• SuperFrost slides and coverslips (Menzel, Braunschweig) 
• Zeiss inverted microscope (Zeiss, Jena) 
• Zeiss laser scanning microscope (Zeiss, Jena) 
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2.2 Methods 
 
2.2.1 Human umbilical vein endothelial cell (HUVEC) preparation and culture   
 
HUVEC were isolated using 0.1 % collagenase and cultured on 0.2 % gelatin-coated 
75-cm2 flasks in M199 supplemented with 20 % heat-inactivated serum (15 % FCS, 
5 % human serum), 7.5 µg/ml endothelial cell growth supplement (ECGS), 7.5 U/ml 
heparin-Na, 100 U/ml penicillin-streptomycin. Cells were maintained at 37°C in 5 
% CO2. Confluent cultures were detached by brief treatment with trypsin-EDTA 
(0.05 %/0.02 %) and plated onto 60-mm, 90-mm dishes, or tissue culture inserts for 
stimulation and migration experiments. All experiments were performed with HUVEC 
monolayers of the second passage.  
 
2.2.2 Mouse lung endothelial cell (MLEC) preparation and culture 
 
Isolation of cells from murine lung 
 
MLEC from wild type and PI3Kγ knockout mice were prepared using a modified 
method from Kuhlencordt et al. (2004). Briefly, animals were sacrificed by cervical 
dislocation and soaked in 70 % ethanol. Their lungs were collected in 20 ml of ice-cold 
DMEM. After removing the hilus region from each lobe, the lungs were minced into 
small pieces under the laminar flow cabinet and digested with 0.1 % collagenase A for 
1 h at 37°C. The digest was triturated through a blunt 14-gauge needle and passed 
through a 100-µm plastic mesh. Cells were pelleted at 300 x g for 10 min and 
resuspended in 15 ml of culture medium, called “plus medium” (preparation see 
below). The cell suspension was plated in a T75 flask precoated with 0.1 % gelatin. 
The next day, cells were washed twice with 5 ml phosphate buffered saline (PBS) 
containing 2 % FCS and cultured for 4 - 5 days. 15 ml of fresh “plus medium” was 
replaced every other day. 
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Selection of endothelial cells from the cell culture 
 
Endothelial cells were selected by sheep anti-rat antibody pre-coated magnetic beads, 
which were additionally incubated with an endothelial-specific antibody (Fig. 5). For 
this purpose, 2x106 magnetic beads per flask were washed three times for 2 min with 
1 ml PBS/2 % FCS and were subsequently incubated with 7.5 µg of purified rat 
anti-mouse CD102 antibody in 500 µl PBS/2 % FCS on a rotator for 2 h at 4°C. Using 
a neodymium-iron-boron permanent magnet, beads were harvested and rinsed with 
1 ml PBS/2 % FCS three times, 2 min each.  
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Figure 5. Magnetic selection  
(Adapted from Dynal product brochure) 
 
 
Antibody-coated beads were resuspended with fresh PBS/2 % FCS buffer. 2x106 
magnetic beads were added to each cell culture flask and incubated for 1 h at 4°C, 
thus allowing binding of antibody-coated beads to endothelial cells. Incubation 
medium was then removed by aspiration and the flask was rinsed with 2 ml 
trypsin-EDTA. Cells were detached by trypsinisation with 2 ml of fresh solution. 
 
Materials and Methods 
 - 27 - 
Reaction was stopped by addition of 2 ml of “minus medium” (preparation see below).  
Cells suspension in a total volume of 15 ml of “minus medium” were transferred to a 
15-ml Falcon tube and endothelial cells were selected in a magnetic field for 10 min. 
To avoid detachment of beads-bound cells that stuck on the wall of the tube, the 
Falcon tube was kept on the magnet and the medium containing unwanted cells was 
gently poured out. The selected endothelial cells were then resuspended in fresh 
“plus medium” and were cultivated in the gelatin-precoated T75 flask containing 15 ml 
of “plus medium” at 37oC, 5 % CO2. When cells were confluent, selection was 
repeated once before plating cells for experiments. By following this procedure, cells 
used in the experiments were, on average, 2 weeks in culture.  
 
• Minus medium:    35 %     DMEM 
35 %     F12 
20 %     FCS     
2 mM     L-glutamine  
100 U/100 µg/ml  penicillin-streptomycin  
 
• Plus medium:     40 %     DMEM 
40 %    F12 
20 %      FCS    
2 mM    L-glutamine  
50 µg/ml    endothelial mitogen 
25 µg/ml    heparin 
100 U/100 µg/ml penicillin-streptomycin  
 
• PBS:      13.6 mM    NaCl 
2.7 mM    KCl 
8.1 mM    Na2HPO4 
1.8 mM    KH2PO4 
pH     7.5  
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2.2.3 Immunohistochemistry   
 
HUVEC and MLEC were stained by using the “ABC staining” system. Briefly, cells 
were cultured on glass coverslips precoated with 0.2 % gelatin in a 24-well plate till 
they were confluent. On the day of experiment, cells were washed twice with 
Hepes-Ca buffer and fixed with 4 % paraformaldehyde (PFA)/PBS for 10 min. The 
coverslip was rinsed twice with PBS buffer, 5 min each, and incubated for 1 h with 
50 µl of anti-mouse or anti-human CD31 antibody (1:50 diluted in PBN buffer). The 
primary antibody was removed by three washes with PBS and the coverslip was 
incubated for 30 min with 50 µl of biotin-conjugated secondary antibody (1: 50 diluted 
in PBN buffer). Afterwards, cells were rinsed three times with PBS, incubated with 50 
µl of streptavidin-conjugated horseradish-peroxidase solution for 30 min and washed 
additionally three times for 2 min with PBS. 50 µl of peroxidase substrate solution 
supplied with 2 µl of 3,3’ diaminobenzidine (DAB) chromogen was given to the 
coverslip and incubated for 10 min. The coverslip was then rinsed with tap water, 
counterstained with hematoxylin for 30 sec and cleared with tap water three times. 
After immediately adding 2 - 3 drops of mounting medium to the coverslip, cells were 
observed by light microscopy and photographed. All procedures were performed at 
room temperature and coverslips were kept wet during the experiment. 
 
• Hepes-Ca buffer:   10 mM   Hepes-Na 
        145 mM  NaCl 
         5 mM    KCl 
         1 mM    MgSO4 
         10 mM   Glucose 
1.5 mM   CaCl2 
         pH 7.4 
 
• PBN buffer:     1x     PBS  
0.1 %    BSA  
0.1 %    Na3N3 
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2.2.4 Endothelial cell transfection  
 
Nucleofection 
 
Endothelial cells were transfected using the AMAXA Biosystems nucleofection 
procedure and according to the manufacturer’s instructions (www.amaxa.com). Briefly, 
cells were washed twice with Hepes buffer and detached using warm trypsin-EDTA 
solution. Trypsinisation was terminated with M199/10 % FCS. Cells were pelleted by 
centrifugation (500 x g, 6 min), resuspended in Hepes-Na buffer and counted in a 
Neubauer hemacytometer. For each transfection, 1 x 106 cells were used. The 
required number of cells was pelleted by centrifugation (500 x g, 6 min) and 
resuspended in HUVEC nucleofector solution (100 µl per transfection). The cell 
suspension was mixed with plasmid DNA (2 µg/100 µl) and transferred to an 
electroporation cuvette. Electroporation was carried out using the nucleofection 
program U-01. Immediately after electroporation, cells were covered with 400 µl warm 
growth medium and plated onto 60-mm dishes containing 3 ml of growth medium. 
After six hours, growth medium was replaced. Cells were analysed for protein 
expression or harvested for cellular assays 24 h post-transfection.  
 
• Hepes-buffer:      10 mM   Hepes-Na  
145 mM   NaCl 
5 mM    KCl 
1 mM    MgSO4 
10 mM    Glucose 
pH 7.4 
 
 
2.2.5 Cell stimulation and cell lysis 
 
HUVEC were seeded onto 60-mm or 90-mm dishes and were washed once and 
serum-starved with M199/ HSA (fatty acid-free) for 5 h. Stimulation was then 
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performed in Hepes-Ca buffer containing 0.25% HSA. Thereafter, cells were washed 
with cold wash buffer and immediately placed on ice. Cells were kept in cold lysis 
buffer (100 µl/60-mm dish) on ice for 15 min and then scraped from the dish using a 
cell scraper. Lysates were collected in eppendorf tubes, sonicated and centrifuged 
(3,000 x g, 6 min, 4°C) to remove the Triton-insoluble material. The cleared lysates 
were transferred to new tubes and 10 µl was set aside for determination of protein 
concentration. Lysates were diluted with 3-fold concentrated Laemmli buffer, heated 
at 95°C for 5 min, and stored at -20°C until use. Protein concentration was determined 
using the Lowry method (Biorad DC Assay) and bovine serum albumin as standard. 
 
• Wash buffer:    50 mM   Tris, pH 7.4 
2 mM   EDTA 
1 mM    EGTA 
50 mM   NaF 
10 mM   Na4P2O7* 
1 mM   DTT* 
(* freshly added) 
 
• Lysis buffer:     1x    washing buffer 
0.1 %    SDS* 
1 %    Triton X-100* 
10 µl/ml   PIC* 
1mM   PMSF* 
(* freshly added) 
   
• Laemmli buffer (3X):   186 mM   Tris, pH 6.8 
10 mM   EDTA 
9 %    SDS 
15 %    Glycerol 
6 %    β-Mercaptoethanol 
0.03 %   Bromophenol Blue 
 
2.2.6 Immunoprecipitation  
 
Protein A-sepharose slurry was washed three times with 500 µl cold lysis buffer. To 
decrease unspecific binding to the beads during incubation with specific antibodies, 
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lysate protein was precleared by adding protein A-sepharose beads. After incubation 
on a rotator at 4°C for 30 minutes, beads were removed by centrifugation (20 000 x g, 
4°C, 5 min). 4 - 12 µg of PI3Kβ-specific antibody was added to each tube containing 
250 - 750 µg of precleared lysate and the mixture was gently rotated overnight at 4°C. 
Immunocomplexes were precipitated by adding 2.5 - 7.5 mg of protein A-sepharose 
slurry.  After 1 h incubation on the rotator at 4°C, beads were collected by 
centrifugation at 4°C, 20 000 x g, 2 min, and washed twice with 500 µl of cold lysis 
buffer. To dissociate the immunocomplex from the beads, the supernatant was 
carefully aspirated and the pellet was boiled for 5 min with 60 µl of 3-fold Laemmli 
sample buffer at 95°C. After cold centrifugation the supernatant was transferred in a 
new Eppendorf tube and frozen at -20°C. Using SDS-PAGE, proteins were separated 
and detected by Western blotting. 
 
2.2.7 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blot analysis 
 
The prepared samples were loaded onto an SDS-PAGE gel and an electrical field was 
applied. Thereafter, the proteins were transferred to PVDF membranes using a 
semi-dry transfer apparatus. Briefly, the sandwich was prepared and the blotting was 
performed at a set current of 1.5mA/cm2 for 2.5 h. Afterwards, the PVDF membrane 
was washed briefly in TBS/Tween-20 solution (TBS-T) and blocked with 5 % nonfat 
dry milk in TBS-T for 1 h. Blots were probed with the appropriate primary and 
secondary antibodies in 1 % bovine serum albumin/TBS-T solution overnight or for 1 h, 
respectively, and detection was carried out using ECL chemiluminescence reagent 
(Amersham) and exposure onto BioMax film (Kodak). For counterstaining, 
immunoblots were stripped by incubating blots in stripping buffer at 56 °C for 30 min, 
with agitation and reprobed with appropriate antibodies. 
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• TBS (10X):     137 mM   NaCl 
2.68 mM   KCl 
25 mM   Tris base 
pH 7.4  
 
• TBS-Tween (TBS-T):  1X    TBS 
0.1 %    Tween-20 
 
• Electrophoresis buffer:  25 mM   Tris 
250 mM   Glycine (pH 8.3) 
0.1 %    SDS 
 
• Transfer buffer:    48 mM   Tris base 
39 mM   Glycine 
0.037 %   SDS 
20 %    Methanol  
 
• Stripping Buffer:    62.5 mM   Tris-HCl, pH 6.7 
2 %   SDS 
0.7 %    β-mercaptoethanol 
 
 
2.2.8 Rac1 GTPase activation assay 
 
The activation of Rac was measured in a pull-down assay, in which the CRIB (Cdc42- 
and Rac-interacting binding) domain of p21-activated kinase (PAK) was used to 
isolate the active GTP-bound form of Rac (Bagrodia et al., 1995). A glutathione 
S-transferase (GST)-tagged PAK CRIB domain was employed in pull-down assays. 
Briefly, cells were seeded on 0.2 % gelatin-coated 90-mm dishes and grown until 90 - 
95 % confluence. On the day of experiment, cells were serum-starved for 5 h and 
pretreated with or without inhibitors during the last 30 min and stimulated with S1P 
(1 µM, 1 min). Cells were placed on ice immediately and lysed in cold lysis buffer 
containing GST-PAK (20 µg/ml), protease inhibitors (10 µl PIC/ml) and GDP (100 µM). 
Lysates were collected, vortexed for 10 sec and cleared by centrifugation at 4°C, 
20.000 x g, 15 min. Protein concentration determination was performed and 200 µg of 
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proteins were transferred to a new tube. GSH-sepharose beads were washed three 
times in 500 µl lysis buffer and 1:1 suspended with cold lysis buffer. 40 µl of this 
suspension was given to each protein sample and incubation was performed on a 
rotator for 30 min, 4°C. Afterwards, the beads were centrifuged, washed three times 
with cold lysis buffer, resuspended with 3-fold concentrated Laemmli buffer and 
heated at 95°C for 5 min. Beads were removed by brief centrifugation at 4°C, 20.000 x 
g. Supernatants were transferred to new tubes and cleared by centrifugation once 
more. Samples were separated by 15 % SDS-PAGE, transferred to PVDF 
membranes and immunoblotted using anti-Rac1 monoclonal antibody (1:1000 diluted 
in 5 % BSA/TBS-T). To avoid transfer of the GST-PAK protein (approx. 30 kDa), gels 
were cut slightly below the 30 kDa band of marker and only the lower part was 
transferred and immunolblotted against Rac1 (21 kDa).  
 
• Lysis Buffer:     50 mM   Tris, pH 7.4 
50 mM   NaCl 
5 mM   MgCl2 
1 mM    EGTA 
1 %    NP-40 
10 %   Glycerol 
10 µl/ml   PIC * 
100 µM   GDP * 
20 µg/ml  GST-PAK * 
* (freshly added) 
 
2.2.8 Migration assay  
 
Cell migration assays were performed using tissue culture inserts (polyethylene 
terephthalate (PET) membrane, 8 µm pores; BD Falcon Inserts) situated in 12-well 
plates. Inserts were coated with 0.2 % gelatin solution overnight at 4 °C. On the day of 
experiment, the gelatin solution was removed by aspiration and inserts were allowed 
to dry. HUVEC grown to sub-confluency.were washed twice with pre-warmed 
Hepes-Ca buffer and detached using trypsin-EDTA solution. Trypsinisation was 
stopped by M199/10 % FCS. Cells were pelleted by centrifugation (500 x g, 6 min) 
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and resuspended in M199/0.25 % HSA. The suspension was diluted to 5 x 105 
cells/ml and 0.5 ml (2.5 x 105 cells) was applied to the upper chamber of the insert. To 
the lower chamber, 1 ml of M199/0.25 % HSA was added. Inhibitors were applied to 
both chambers and incubated for 30 min. Finally, 1 µM S1P was added to the lower 
chamber and the migration apparatus was gently agitated to ensure even distribution 
of the chemoattractant. Migration was allowed to proceed for 4 h at 37°C and 5 % 
CO2.  
 
Medium
Cell suspension
Hematoxylin
staining
Cell 
counting
Incubation
 
 
Figure 6. Transwell plate Migration assay 
 
Hematoxylin Staining 
 
Cells were washed twice using ice-cold Hepes-Ca buffer and fixed with 4 % 
paraformaldehyde in PBS for 10 min. The fixing solution was removed by aspiration 
and inserts were washed twice with double distilled H2O. Inserts were stained with 
hematoxylin for 5 min, washed twice with tap water and incubated for 10 min to allow 
color development. Afterwards, the tap water was removed by aspiration and the 
non-migrated cells were removed by wiping the upper face of the insert with a 
cotton-tip. Inserts were allowed to air-dry overnight in the dark. Using a clean scalpel, 
inserts were carefully excised from their support and embedded onto tissue culture 
slides using Eukitt mounting medium. The number of migrated cells was counted 
using an inverted microscope (Zeiss) at 25-fold magnification and determined as the 
mean of 10 randomly selected fields.   
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2.2.9 Wound Healing Assay  
 
Endothelial cells were seeded on 6-well plates coated with 0.2 % gelatin and allowed 
to achieve confluence. Subsequently, one 1 - 2 mm wide wound area was scratched 
into the monolayer using a 1-ml pipette tip and the position of the denuded area was 
indicated with the help of an ocular grid. Medium was aspirated and dishes were 
rinsed once with PBS. Cells were then incubated with inhibitors for 30 min in 2 ml of 
fresh M199/5 % FCS and subsequently stimulated with 1 µM S1P for 20 h. To 
quantitate the level of cell migration, cells which migrated into the marked areas were 
counted (10 fields per well) using a light microscope.  
 
2.2.10 Total RNA isolation 
 
Total RNA was isolated from HUVEC and MLEC using Trizol reagent. Cells were 
lysed directly in a 90-mm culture dish by adding 1.6 ml of Trizol reagent, distributing 
the reagent evenly and passing the cell lysate several times through a pipette. The 
homogenised samples were collected in a 2-ml tube and incubated for 5 min at room 
temperature to permit the complete dissociation of nucleoprotein complexes. 0.2 
ml/ml of chloroform was applied to the samples and mixed for 15 sec. After 3 min 
incubation, samples were centrifuged at 12.000 x g, 4°C for 15 min. The colorless 
upper aqueous phase which contains RNA was carefully transferred to a new tube. 
RNA was precipitated by adding 0.5 ml/ml of isopropanol and collected by 
centrifugation (12.000 x g, 10 min 4°C). The pellet was washed with 1.5 ml of cold 
75% ethanol. After centrifugation (7500 x g, 5 min, 4°C) the pellet was allowed to dry 
at room temperature. Finally, the RNA sample was dissolved in 50 µl diethyl 
pyrocarbonate (DEPC) water and stored at -20°C until use. The concentration of RNA 
was determined as the absorbance at 260 nm in spectrophotometer, where 1 unit at 
260 nm corresponds to 40 µg of RNA per ml. 
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2.2.11 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
 
RT-PCR was performed using the Qiagen OneStep RT-PCR Kit (QIAGEN) to detect 
mRNA expression of p101 and p87 in HUVEC and MLEC. With the kit, reverse 
transcription and polymerase chain reaction was allowed to take place sequentially in 
the same tube. For each reaction, 1.0 μg RNA and 500 nM forword/reverse primers 
were used. The conditions of reaction are shown as below:  
 
Human p101- or p87-specific RT-PCR 
 
• Reverse transcription:   30 min  50°C 
• Initial PCR acivation:   15 min  95°C 
• 3-step cycling: 
- Denaturation:    1 min  94°C 
- Annealing:     1 min  55°C 
- Extension:     1 min  72°C 
- Number of cycles:   30 cycles 
• Final extension:    10 min  72°C 
 
Mouse p101- or p87-specific RT-PCR 
 
• Reverse transcription:   30 min  50°C 
• Initial PCR acivation:   15 min  95°C 
• 3-step cycling: 
- Denaturation:    1 min  94°C 
- Annealing:     1 min  55°C 
- Extension:     1 min  72°C 
- Number of cycles:   35 cycle 
• Final extension:    10 min  72°C 
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PCR reaction products were mixed with 5-fold concentrated DNA loading buffer and 
separated by electrophoresis on 1.0 % agarose gel in Tris-acetate buffer (TAE buffer) 
containing 0.5 μg/ml ethidium bromide and visualised using a UV illuminator. 
 
• 5× DNA sample buffer:  0.25%  Bromphenol blue 
0.25%  Xylencyanol 
30%  Glycerol 
 
• 1x TAE buffer:    40 mM  Tris-acetic acid 
1 mM  EDTA 
pH 8.3           
 
 
2.2.12 Statistical analysis 
 
All data are given as means ± SEM of three to five independent experiments. To 
determine the statistical significance of the described results, analysis of variance with 
Bonferroni’s correction for multiple comparisons, or t-tests were performed. A p value 
of < 0.05 was accepted as statistically significant. 
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3. Results 
 
3.1 Characterisation of endothelial cells 
 
Our studies were performed in HUVEC and MLEC from wild type and PI3Kγ knockout 
mice which lack the catalytic subunit p110γ. p110γ-/- mice were generated a few years 
ago (Hirsch et al., 2000; Li et al., 2000; Sasaki et al., 2000), while the p110β knockout 
mouse is not available. To characterise human and particularly murine endothelial 
cells, they were specifically labeled with anti-CD31 human- or mouse-specific 
antibodies using the “ABC staining” system. As shown in Fig. 7, most cells showed 
positive staining compared to control cells which were not incubated with the 
anti-CD31 antibody. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 7. Photomicrographs of human or mouse-specific CD31 immuno- 
staining. HUVEC and MLEC were seeded on gelatine-coated coverslips situated in 
24-well plates. Cell monolayer was stained without (upper lane) or with (lower lane) 
anti-CD31 antibody. Nuclei were stained with Hematoxylin. Arrows point to the 
magnet beads from mouse lung endothelial cell preparation. 
 
control control
HUVEC MLEC PI3Kγ -/- MLEC PI3Kγ +/+ 
anti-human CD31 
control 
anti-mouse CD31 anti-mouse CD31 
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3.2 PI3K expression in endothelial cells  
 
3.2.1 Expression of catalytic subunit of endogenous PI3K isoforms in HUVEC 
and MLEC  
 
PI3K class I is subgrouped into class IA and class IB. Class IA contains three isoforms 
p110α, β, and δ, whereas p110γ has been characterised as the unique isoform of 
PI3K class IB that is activated by GPCR. Its expression has been initially believed to 
be restricted to cells of the haematopoietic lineage. Recent findings indicated the 
existence of PI3Kγ in smooth muscle cells (Bacqueville et al., 2001) and endothelial 
cells (Puri et al., 2005) suggesting that PI3Kγ possesses a broader distribution pattern 
than previously thought.  
In the present study, we investigated the presence of the PI3Kγ catalytic subunit, 
p110γ, in HUVEC and MLEC using Western blot analysis. Fig. 8 confirms the 
existence of p110γ in human and wild type murine endothelial cells at the protein level 
using a specific antibody against the N-terminus of p110γ. On the other hand, as 
expected, the protein expression of p110γ was not detectable in cells that were 
isolated from p110γ-null mice (Fig. 8). 
 
IP: p110β
MLEC
WB: p110γ
HUVEC
WB: p110β
p110γ +/+ p110γ -/-
MLEC
 
 
Figure 8. Expression of p110γ and p110β in endothelial cells.  HUVEC or 
MLEC were cultured on 60 mm-dishes and lysed with lysis buffer. 
PI3Kβ-immunocomplexes or protein lysates (PI3Kγ) were separated by 
SDS-PAGE on 10 % gels. PI3K isoforms were detected by immunoblotting 
using specific antibodies against p110β or p110γ. Protein expression in 
HUVEC, wild type and p110γ knockout MLEC is shown.  
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PI3Kβ is another member of class I PI3Ks which is partially activated by GPCR. We 
also investigated its presence in human and mouse endothelial cells by employing an 
antibody specifically directed to p110β to immunoprecipitate the protein and to identify 
its expression in Western blots. Fig. 8 shows the expression of PI3Kβ in HUVEC and 
MLEC. Interestingly, the absence of PI3Kγ protein in knockout MLEC had no effect on 
the protein level of PI3Kβ.  
 
3.2.2 Expression of regulatory subunits of PI3Kγ in HUVEC and MLEC 
 
Several years ago, a protein, termed p101, has been investigated and described as 
an essential adaptor protein of PI3Kγ (Stephens et al., 1997). More recent studies 
depicted the presence of another regulatory subunit of PI3Kγ, p87, in human 
embryonic kidney epithelial cell line, HEK293 (Voigt et al., 2006). We also investigated 
whether these adaptors are expressed in human and murine endothelial cells. Since 
specific antibodies are not available to detect protein expression, we examined the 
expression of p101 and p87 at the mRNA level. According to human or murine 
sequences of p101 and p87, oligonucleotide primers were designed and employed in 
RT-PCR as described. The expected products corresponding to different size (human 
p101: 481 bp, human p87: 607 bp; mouse p101: 405bp, mouse p87: 169 bp) were 
separated and detected by 1% agarose gel electrophoresis. A human T cell line, 
Jurkat, and a murine myeloid cell line, CD32, both expressing p101 and p87, were 
employed as positive controls for human and mouse samples, respectively.  
Neither p101 nor p87 mRNA was detected in HUVEC, although the expression of both 
adaptors was clearly seen in control cells (Fig. 9). In contrast, it is interesting to note 
that MLEC showed the presence of both p101 and p87, suggesting that the 
expression of both regulatory subunits may depend on the cell type and/or species. 
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Figure 9. mRNA expression of PI3Kγ regulatory subunits p87 and p101 in human 
(A) and murine (B) endothelial cells. Total RNA was isolated from HUVEC or normal 
and p110γ knockout MLEC. RT-PCR was performed using the Qiagen OneStep 
RT-PCR Kit (0.5 µg RNA and 50 pmol forward/reverse primers). RT-PCR products 
were separated on 1% agarose gels containing 0.5 µg/ml ethidium bromide and 
visualised using UV light. Samples prepared from Jurkat and CD32 cell lines were used 
as positive control for human and mouse cells, respectively. 
 
 
3.3 S1P-induced protein phosphorylation in endothelial cells 
 
3.3.1 Effect of PI3K inhibitors on S1P-induced phosphorylation of Akt in HUVEC 
 
Akt is an essential signalling protein involved in the regulation of cellular responses 
such as cell survival and migration. Many agonists are able to influence Akt activation 
by regulating its phosphorylation state. In the present study, we show that S1P 
triggers a rapid, transient and reversible Akt phosphorylation in HUVEC. Using a 
specific antibody against the phosphorylated serine 473 residue of Akt, a 
time-dependent Akt phosphorylation in response to stimulation with 1 µM S1P was 
detected from 15 sec to 10 min with the peak observed at 2 min (Fig.10).  
Previous reports have demonstrated that S1P is able to stimulate Akt activation via a 
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Gi/PI3K signalling pathway in many cell types. In this study, HUVEC were pretreated 
with the Gi/o protein inhibitor PTX and the PI3K inhibitor wortmannin which restrains all 
members of class I PI3Ks. As presented in Fig. 11, the level of phosphorylated Akt 
following S1P stimulation (1 µM, 2 min) was markedly reduced by PTX (100 ng/ml, 3 h) 
or wortmannin (100 nM, 30 min) treatment, confirming earlier findings that both Gi 
protein and PI3K are required for S1P-mediated Akt activation. 
Since we were able to demonstrate that both PI3Kβ and PI3Kγ are expressed in 
HUVEC and since both isoforms have been described to be targets of Gi protein βγ 
subunits, we investigated whether one or both of these PI3K isoforms mediate 
S1P-induced Akt phosphorylation.  
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Figure 10*. Time-dependency of S1P-induced Akt phosphorylation in 
HUVEC. HUVEC were serum starved with M199/0.25 % HSA for 5 h in 60-mm 
dishes and subsequently stimulated with 1µM S1P for different time points (0, 
0.25, 0.5, 1, 2, 5, 10 min). Lysis buffer was directly applied into dishes and the 
lysates were collected by centrifugation. (A). Lysates were analysed by 
immunoblotting using a specific antibody against phosphorylated Akt (serine 473) 
or, after stripping, total Akt. One of three similar blots is shown. (B). Densitometry 
analysis of pooled data showing the ratio between phosphorylated Akt and total 
Akt after S1P stimulation. The data represent mean values ± SEM derived from 
three independent experiments.*p < 0.05 versus untreated control. 
(* Experiments were performed by Gunter Ehrlich)  
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Therefore, HUVEC were pretreated with distinct inhibitors TGX-221 and AS-252424, 
which specifically inhibit the activation of PI3Kβ and PI3Kγ, respectively. In Fig. 11, we 
present the interesting result that treatment of cells with the PI3Kβ-specific inhibitor 
TGX-221 (100 nM, 30 min) completely abrogated S1P (1 µM, 2 min)-mediated Akt 
phosphorylation which was comparable to the effects of PTX and wortmannin. 
Surprisingly, in the same studies, no alteration of S1P-induced Akt activation was 
observed when cells were preincubated with the PI3Kγ-specific inhibitor AS-252424 
(1 µM, 30 min). These results indicated the requirement of PI3Kβ, but not PI3Kγ, for 
S1P-mediated activation of Akt in human endothelial cells.  
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Figure 11*. Effect of Gi protein and PI3K inhibitors on S1P-stimulated Akt 
phosphorylation in HUVEC. HUVEC were serum starved with M199/0.25 % 
HSA for 5 h in 60-mm dishes and pretreated with different inhibitors for 30 min 
(100 nM wortmannin (WM), 100 nM TGX-221 (TGX), 1 µM AS-252424 (AS)) or 
3 h (100 ng/ml pertussis toxin (PTX)). Subsequently, stimulation with 1µM S1P 
for 2 min was performed. (A). Cells were lysed in lysis buffer and the lysates 
were analysed by immunoblotting using a specific antibody against 
phosphorylated Akt (serine 473) or, after stripping, total Akt. One of four similar 
blots is shown. (B). Densitometry analysis of pooled data showing the ratio 
between phosphorylated Akt and total Akt after S1P stimulation. The data 
represent mean values ± SEM derived from four independent experiments. *p 
< 0.05 versus S1P-stimulated control. Con, control. 
(* Experiments were performed by Gunter Ehrlich.)  
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3.3.2 S1P-induced phosphorylation of Akt in MLEC 
 
PI3Kγ knockout mice have been proved to be an excellent tool to study the function of 
PI3Kγ in biological responses. With the respect to its role in Akt activation, some 
groups have shown that Akt phosphorylation induced by GPCR-coupled agonists, 
dsdf 
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Figure 12. S1P-induced Akt phosphorylation in wild type and p110γ 
knockout MLEC. Wild type and knockout MLEC were serum starved for 5 h and 
stimulated with 1µM S1P for 2 min. (A). Cell lysates were analysed by 
immunoblotting using a specific antibody against phosphorylated Akt (serine 473) 
or, after stripping, total Akt. One of four similar blots is shown. (B). Densitometry 
analysis of the blots of phosphorylated Akt and total Akt under basal conditions 
or after S1P stimulation shown in Fig. A. The data represent mean values ± 
SEM derived from four independent experiments. 
 
 
such as fMLP, C5a and IL-8, was decreased in p110γ-/- neutrophils (Hirsch et al., 2000; 
Sasaki et al., 2000). In the present study, we addressed whether the inhibition of 
S1P-mediated Akt phosphorylation can also be observed in p110γ-/- endothelial cells. 
Studies were performed with MLEC isolated from normal and p110γ-deficient mice. 
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Fig. 12 shows that the absence of PI3Kγ protein in p110γ knockout cells was not able 
to alter the S1P (1 µM, 2 min)-elicited level of phosphorylated Akt. This finding further 
confirms our results obtained in inhibitor studies in HUVEC and indicates that PI3Kγ 
was not required for S1P-induced Akt activation in endothelial cells.  
 
3.3.3 Effect of PI3K inhibitors on S1P-induced phosphorylation of eNOS in 
HUVEC 
 
eNOS is a well-known downstream effector of Akt in response to many agonists. 
Rikitake et al. have reported that S1P is also able to phosphorylate eNOS via a Gi 
protein/PI3K/Akt pathway, thus leading to increased NO production in endothelial 
cells (Rikitake et al., 2003). However, the PI3K isoform involved was not specified, 
although Igarashi et al. suggested that PI3Kβ might be activated by S1P (Igarashi et al. 
2001). Therefore, we evaluated the effect of distinct PI3K inhibitors on S1P-induced 
eNOS phosphorylation in HUVEC.  
In agreement with previous reports, we show that 1 µM S1P significantly stimulated 
eNOS phosphorylation at the serine 1177 residue by about 4-fold after 2 min, which 
was completely inhibited by 100 ng/ml PTX. However, pretreatment of cells with 100 
nM wortmannin for 30 min, only partially reduced S1P-induced eNOS phosphorylation 
(Fig 13), although Akt was completely inhibited under these conditions. Furthermore, 
we determined TGX-221-induced effects on eNOS phosphorylation. Interestingly,  
preincubation of cells with 100 nM of the p110β-specific inhibitor TGX-221 for 30 min 
exhibited only approximately 35 % reduction of eNOS phosphorylation in response to 
S1P ( 1 µM, 2 min), while Akt activation was fully abolished in the parallel experiments. 
Moreover, no alteration of eNOS phosphorylation was detected upon AS-252424 
pretreatment (1 µM, 30 min). These results show that PI3Kβ partially mediates eNOS 
phosphorylation whereas PI3Kγ is not involved. Apart from the PI3K/Akt pathway, 
however, other protein kinases seem to contribute to S1P-induced eNOS 
phosphorylation as well. 
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Figure 13*. Effect of Gi protein and PI3K inhibitors on S1P-stimulated 
eNOS phosphorylation in HUVEC. HUVEC were serum starved with 
M199/0.25 % HSA for 6 h in 60-mm dishes and pretreated with different 
inhibitors for 30 min (100 nM wortmannin (WM), 100 nM TGX-221 (TGX), 1 µM 
AS-252424 (AS)) or 3 h (100 ng/ml pertussis toxin (PTX)). Subsequent 
stimulation of 1µM S1P was performed for 2 min. (A). Cells were lysed as 
described and the lysates were analysed with immunoblotting using a specific 
antibody against phosphorylated eNOS or, after stripping, total eNOS. One of 
four similar blots is shown. (B). Densitometry analysis of pooled date showing 
the ratio between phosphorylated Akt and total Akt after S1P stimulation. The 
data represent mean values ± SEM derived from four independent 
experiments. *p < 0.05 versus S1P-stimulated control. Con, control. 
(* Experiments were performed by Gunter Ehrlich.) 
 
 
3.3.4 S1P-induced phosphorylation of eNOS in MLEC 
 
S1P-induced eNOS phosphorylation was also analysed in MLEC isolated from 
p110γ-negative murine cells (Fig. 14). 1 µM S1P (2 min) obviously increased eNOS 
phosphorylation in knockout MLEC. However, p110γ-negative cells did not show a 
significant alteration on the level of eNOS phosphorylation compared to that observed 
in wild type cells (Fig. 14).  
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These results confirm that S1P stimulates phosphorylation of eNOS partially via a Gi 
protein/PI3Kβ/Akt signalling pathway, whereas PI3Kγ is not involved.  
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Figure 14. S1P-induced eNOS phosphorylation in wild type and p110γ 
knockout MLEC. Wild type and p110γ knockout MLEC were serum starved for 
5 h and subsequently stimulated with 1µM S1P for 2 min. (A). Cell lysates were 
analysed by immunoblotting using a specific antibody against phosphorylated 
eNOS (serine 1177) or, after stripping, total eNOS. One of four similar blots is 
shown. (B). Densitometry analysis of pooled data showing the ratio between 
phosphorylated eNOS and total eNOS under basal conditions or after S1P 
stimulation. The data represent mean values ± SEM from three independent 
experiments.  
 
 
3.4 S1P-stimulated activation of the small GTPase Rac in endothelial cells 
 
3.4.1 S1P-mediated Rac activation in HUVEC  
 
The Rho family small GTPases such as RhoA, Cdc42 and, in particular, Rac-1 are 
essential in regulation of actin cytoskeletal organisation and cell movement. Recent 
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investigations have been focused on the interaction between PI3K/Akt and Rac 
signalling pathways in S1P-stimulated cells.  
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Figure 15. Time-dependency of S1P-induced Rac activation in HUVEC. 
HUVEC were plated on 60-mm dishes and Rac pull-down assays were 
performed when cells were confluent. Briefly, HUVEC were starved with 
M199/0.25 % HSA for 5 h and stimulated with 1 µM S1P. Cells were lysed with 
lysis buffer containing GST-PAK (20 µg/ml). Lysates were collected by 
centrifugation and the supernatant was further incubated with GSH-Sepharose 
beads for 30 min to pull-down GTP-loaded Rac. Samples were separated on 
SDS-PAGE and GTP-bound or total Rac were detected by immunoblotting 
using a specific antibody against Rac-1. (A). Cells were stimulated with 1 µM 
S1P for different time points (0, 0.25, 0.5, 1, 2, 5, 10 min). Representative blots 
are shown. (B). Densitometry analysis of Rac-GTP blots. The data represent 
mean values ± SD of two independent experiments.  
 
 
In order to investigate the role of PI3K isoforms in S1P-induced Rac activation, we first 
characterised the effect of S1P on endogenous Rac-1 activity in HUVEC. The 
activation of Rac was measured in a pull-down assay as described above. As shown 
in Fig. 15, stimulation of HUVEC with 1 µM S1P triggered a rapid and potent activation 
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Figure 16. Concentration-dependency of S1P-induced Rac activation in 
HUVEC. Cells were plated on 60-mm dishes and were starved with M199/0.25 
% HSA for 5 h. After S1P stimulation, cells were lysed with lysis buffer 
containing GST-PAK (20 µg/ml). Lysates were collected by centrifugation and 
the supernatant was further incubated with GSH-Sepharose beads for 30 min to 
pull-down GTP-bound Rac..Samples were separated on SDS-PAGE. 
GTP-bound or total Rac were detected by immunoblotting using a specific 
antibody against Rac-1. (A). Different concentration (10-9 - 10-5 M) of S1P were 
applied to cells for 1 min. Representative blots are shown. (B). Densitometry 
analysis of Rac-GTP blots. The data represent mean values ± SD of two 
independent experiments.  
 
 
of Rac in a time-dependent manner. GTP-bound Rac was detectable after 15 sec and 
sustained up to 10 min with a peak observed at 1 min.  
In addition, Rac activation is dependent on S1P concentration. We observed a slight 
activation of Rac with nanomolar concentrations of S1P, but 1 µM and 10 µM were 
required to achieve a significant response (Fig. 16). Thus, 1 µM S1P stimulation for  
1 min was used as a standard condition for further GTP-Rac pull-down experiments.  
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3.4.2 Effect of PI3K inhibitors on S1P-mediated Rac activation in HUVEC  
 
To examine whether PI3Kβ and/or PI3Kγ isoforms are involved in mediating Rac 
activation in HUVEC, cells were pretreated with the PI3Kβ-specific inhibitor TGX- 221 
(100 nM, 30 min) or the PI3Kγ-specific inhibitor AS-252424 (1 µM, 30 min) before 
adding 1 µM S1P to the dishes. S1P-stimulated GTP-bound Rac was diminished by 
both inhibitors at a similar level (TGX-221: 52%, AS-252424: 46%), whereas basal 
levels of GTP-Rac were unaltered. This result implies that both isoforms are 
necessary, at least in part, for S1P-induced Rac activation (Fig 17). 
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Figure 17. Effect of PI3K inhibitors on S1P-induced Rac activation in 
HUVEC. HUVEC were serum starved for 5 h and inhibitors (100 nM wortmannin 
(WM), 100 nM TGX-221 (TGX) and 1 µM AS-252424 (AS)) were applied during 
the last 30 min. Cells were subsequently stimulated with 1 µM S1P for 1 min 
and lysed with lysis buffer containing GST-PAK domain (20 µg/ml). Supernatant 
was incubated with GSH-Sepharose beads for 30 min to pull-down GTP-bound 
Rac. Immunoblotting analysis was performed using specific antibody against 
Rac1. (A). One of five similar blots is shown. (B). Densitometry analysis of 
Rac-GTP blots is shown. The data represent the mean values ± SEM derived 
from five independent experiments. *p < 0.05 versus S1P-stimulated control. 
Con, control. 
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3.4.3 Effect of PI3K inhibitors on S1P-mediated Rac activation in wild type and 
PI3Kγ knockout MLEC 
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Figure 18. Effect of PI3K inhibitors on S1P-induced Rac activation in MLEC. Wild type 
and p110γ-/- MLEC were serum starved for 5 h and inhibitors (100 nM TGX-221 (TGX) or  
1 µM AS-252424 (AS), 30 min) were applied during the last 30 min. Cells were 
subsequently stimulated with 1 µM S1P for 1 min and lysed with lysis buffer containing 
GST-PAK domain (20 µg/ml). Supernatant was incubated with GSH-Sepharose beads for 
30 min to pull-down GTP-bound Rac. Immunoblotting analysis was performed using a 
specific antibody against Rac1. (A). One of five similar blots is shown. (B). Densitometry 
analysis of the Rac-GTP-blots is shown. The data show mean values ± SEM derived from 
five representative experiments. *p < 0.05 versus S1P-stimulated control in wild type MLEC. 
Con, control;  
 
 
We also performed studies with specific PI3K inhibitors in murine endothelial cells (Fig. 
18). In response to S1P stimulation (1 µM, 1 min), Rac activation was approximately 
4-fold increased in wild type MLEC. When these cells were pretreated with 100 nM 
TGX-221 or 1 µM AS-252424, 30 min, S1P-induced activation of Rac was notably 
decreased (47% or 52%, respectively). Moreover, compared to wild type MLEC, 
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p110γ-negative MLEC displayed a 57% decrease of S1P-stimulated Rac activation. In 
addition, pretreatment of p110γ-/- cells with TGX-221 (100 nM, 30 min) was able to 
further downregulate Rac activation by about 50%. 
 
 
3.5 S1P-induced migration in endothelial cells 
 
3.5.1 S1P-mediated migration in HUVEC and MLEC 
 
S1P has been demonstrated to be a potent stimulus of endothelial cell motility. Before 
investigating the role of PI3K isoforms in S1P-induced migration, we characterised the 
effect of S1P on migration of HUVEC and MLEC under our experimental conditions. 
The in vitro migration assay was performed using the “Transwell insert” system.  
Previous data from our group have shown that S1P induced HUVEC migration in a 
time (2 and 4 h)- and concentration (0.01 – 10 µM)-dependent manner (data not 
shown). Furthermore, the migratory response to S1P was detected in MLEC. As 
shown in Fig. 19, MLEC revealed a significantly increased migratory response 
towards S1P (1 µM, 4 h).  
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Figure 19. S1P-induced directional migration of wild type MLEC. 2.5 x 105 
cells were seeded onto tissue culture insert. S1P was applied to the lower 
chamber and cells were allowed to migrate. Inserts were stained with hematoxylin 
and the number of migrated cell was counted. Migration was measured after 
stimulation of MLEC with S1P (1 µM, 4 h). Data are given as mean values ± SD 
(n=2). Con, control 
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3.5.2 Effect of PI3K inhibitors on S1P-mediated migration  
 
Several studies have reported that S1P induces cell motility via a Gi 
protein-dependent pathway and the response was markedly reduced by PTX. 
Previous studies from our group confirmed these findings (data not shown). Moreover,  
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Figure 20. Effect of PI3K inhibitors on S1P-mediated migration. 2.5 x 105 HUVEC were 
seeded onto tissue culture insert in serum free medium. Cells were preincubated with 100 nM 
wortmannin (WM), 100 nM TGX-221 (TGX), 1µM AS-252424 (AS) and the combination of 
TGX and AS (T/A) for 30 min, respectively. Inhibitors were added to both upper and lower 
chambers, whereas 1 µM S1P was applied only to the lower chamber. Cells were allowed to 
migrate for 4 h. Thereafter, inserts were stained with hematoxylin and the number of migrated 
cell was counted. (A). Representative microscopic images of cells migrating in the presence 
of S1P with or without inhibitor treatment are shown. (B).The figure shows mean values ± 
SEM from four independent experiments. *p < 0.05 versus S1P-stimulated control. Con, 
control.  
 
 
the involvement of PI3Ks in S1P-induced cell motility has been shown and 
accordingly, the non-selective PI3K inhibitor wortmannin (100 nM, 30 min) caused a 
significant reduction of S1P-triggered cell migration (47 %) in our study (Fig. 20).  
Although it has been demonstrated that S1P-induced endothelial migration depends 
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on PI3K activation, the nature of PI3K isoforms involved has not yet been identified. 
Both PI3K isoforms, PI3Kβ and PI3Kγ, may contribute to cell migration via 
Gi-dependent pathways. In particular, PI3Kγ has been shown to be required for the 
migration of murine monocytes and neutrophils in response to chemotactic stimuli 
(Hirsch et al., 2000)  
In the present study, we employed the inhibitors, TGX-221 and AS-252424, in 
transwell migration assays. As shown in Fig. 20, treatment of HUVEC with either 100 
nM TGX-221 or 1 µM AS-252424 decreased migration by 32 % and 33 %, 
respectively. The combination of two inhibitors led to a reduction of 50 %, which was 
comparable to the level of inhibition achieved by wortmannin (47 %). These results 
illustrate that both PI3Kβ and PI3Kγ are important for directional cellular motility 
towards an S1P gradient.  
 
3.5.3 Effect of PI3Kβ and γ overexpression on S1P-induced migration  
 
In a second series of experiments, we overexpressed cDNA plasmids encoding a 
catalytically inactive mutant of PI3Kβ (p110β KR) or PI3Kγ (p110γ KR) in HUVEC, 
respectively. Transfections were carried out using the AMAXA Biosystems 
nucleofection procedure. The empty vector pcDNA3 was used as a control. Cells were 
transfected with 2 µg pcDNA3, p110β KR and p110γ KR plasmids, respectively. The 
level of the overexpressed proteins was detected in immunocomplexes (PI3Kβ) or 
protein lysates (PI3Kγ) by Western blotting (Fig. 21). Compared to pcDNA3 control, 
overexpression of p110β KR mutant inhibited the directional cell movement towards  
1 µM S1P by 43 % (Fig. 21A). Similarly, overexpression of p110γ KR mutant led to a 
40 % reduction of S1P-induced migration (Fig. 21B). 
Taken together, our findings implicate that both PI3Kβ and PI3Kγ are involved in the 
regulation of S1P-induced chemotaxis of HUVEC. 
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Figure 21. Effect of overexpression of p110ß KR or p110γ KR mutants on 
S1P-mediated migration. 1.0 x 106 HUVEC were transfected with 2 µg of 
p110ß KR (A) or p110γ KR (B) mutant cDNA plasmids, respectively, using the 
AMAXA Biosystems nucleofection procedure. 24 h post-transfection, 2,5 x 105 
cells were detached and seeded onto tissue culture inserts in serum free 
medium.1 µM S1P was applied to the lower chamber. Cells were allowed to 
migrate for 4 h. Thereafter, inserts were stained with hematoxylin and the 
number of migrated cell was counted. An empty vector pcDNA3 was used as 
control. Data are given as mean values ± SEM (n=4 for p110ß KR mutant 
overexpression and n=5 for p110γ KR mutant experiments. Overexpression of 
mutants was detected in immunocomplexes (PI3Kβ) or protein lysates (PI3Kγ) 
by Western blotting with specific antibodies against PI3Kβ or PI3Kγ. *p < 0.05 
versus S1P-stimulated pcDNA-transfected control. 
 
 
3.5.4 Effect of PI3Kγ knockout on S1P-mediated migration in murine cells 
 
To further explore the role of PI3Kγ in S1P-mediated endothelial migration, wild type 
and p110γ-/- MLEC were allowed to migrate towards 1 µM S1P for 4 h as described. 
S1P was able to stimulate murine endothelial cell migration in wild type and p110γ-/- 
MLEC. However, the absence of PI3Kγ catalytic subunit in these cells resulted in 48 % 
inhibition of cellular motility compared to wild type control (Fig. 22). To investigate 
whether PI3Kβ has an additional effect on migration in p110γ knockout cells, we 
pretreated normal and p110γ-/- MLEC with 100 nM TGX-221 (Fig. 22). Employment of 
the inhibitor significantly attenuated migration in wild type (51 ± 9 %) and also in p110γ 
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knockout cells (55 ± 9.8 %). On the contrary, 1µM AS-252424 had no effect on 
migration of p110γ-null MLEC any longer (data not shown). These results confirm our 
data from inhibitor study in HUVEC showing that TGX-221 and AS-252424 impaired 
cell migration at a similar extent. In conclusion, our results suggest that PI3Kβ and 
PI3Kγ contribute equally to S1P-stimulated chemotaxis in human and murine 
endothelial cells. 
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Figure 22. S1P-mediated migration in wild type and p110γ knockout MLEC. 
Cells (1.0 x 105) were seeded onto tissue culture inserts in serum free medium. 
100nM TGX-221 was added to both upper and lower chamber for 30 min, 1 µM 
S1P was additionally applied to the lower chamber and a 4 h migration assay 
was performed. Data are given as mean values ± SEM (n=3). *p < 0.05 versus 
S1P-stimulated control. 
 
 
3.5.5 Effect of eNOS inhibitor (L-NAME) on S1P-mediated migration  
 
eNOS has been described to be an essential mediator in the regulation of endothelial 
cell migration in response to growth factors. However, studies on the role of eNOS in 
S1P-stimulated cell migration showed inconsistent results. To examine the function of 
eNOS in endothelial cell migration under our experimental conditions HUVEC were 
pretreated with 1 mM NOS inhibitor L-NAME for 30 min and consequently stimulated 
with 1 µM S1P for 4 h. As shown in Fig 23, L-NAME was unable to inhibit transwell cell 
migration towards S1P, suggesting the dispensability of eNOS activation in this 
reaction.  
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Figure 23. Effect of eNOS inhibitor on S1P-mediated migration. HUVEC (1.0 
x 105) were seeded onto tissue culture insert in serum free medium. Cells were 
subsequently preincubated with 1 mM L-NAME for 30 min and then allowed to 
migrate towards S1P (1 µM) for 4 h. Thereafter, inserts were stained with 
hematoxylin and the number of migrated cell was counted. The figure shows 
mean values ± SEM from five independent measurements.  
 
 
3.6 S1P-induced wound healing in endothelial cells 
  
3.6.1 Effect of PI3K inhibitors on S1P-mediated wound healing in HUVEC  
 
In contrast to transwell migration, which measures the movement of cells along a 
chemotactic gradient, the wound healing assay indicates the capability of cell 
movement induced by a constant dose of a stimulus. The mechanisms of regulating 
cell chemotaxis may differ from the control of chemokinesis and interestingly, PI3K 
isoforms probably have distinct functions in these processes. For instance, PI3Kγ has 
been shown to regulate neutrophil chemotaxis primarily by controlling the direction of 
cell migration (Hannigan et al., 2001). Moreover, it has also been indicated that 
overexpression of dominant negative mutant of p85 regulatory subunit reduced 
S1P-stimulated wound repair in BAEC (Rikitake et al., 2002). Thus, it becomes 
interesting to investigate the role of PI3K isoforms in a wound healing assay.  
Therefore, HUVEC were pretreated for 30 min with 100 nM TGX-221 and 1 µM 
AS-252424. 1 µM S1P was applied and cells were allowed to move to the wound 
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region for 20 h. The number of migrated cells is shown in Fig. 24. S1P stimulated an 
approximately 2-fold increase of migration in HUVEC wound healing assays, which 
was significantly diminished by TGX-221. On the contrary, no effect of AS-252424 
was detected in the same experiments. Both inhibitors did not alter the basal level of 
wound healing.    
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Figure 24. Effect of PI3K inhibitors on S1P-mediated wound healing in 
HUVEC. HUVEC were cultivated in 6-well plates and a wound area was 
scratched in the confluent monolayer. 100 nM TGX-221 or 1 µM AS-252424 
was applied for 30 min. Cells were subsequently stimulated with 1 µM S1P for 
20 h. The number of migrated cells was evaluated under microscope. The figure 
shows mean values ± SEM from four independent experiments. *p < 0.05 
versus S1P-stimulated control. 
 
 
3.6.2 Effect of PI3Kβ and PI3Kγ overexpression on S1P-induced wound healing  
 
To further confirm our results, we overexpressed inactive mutants of p110β and 
p110γ, respectively, to investigate whether these mutants downregulate 
S1P-mediated migration in wound healing assays. HUVEC were transfected with  
2 µg of control empty vector pcDNA3, p110β KR and p110γ KR mutant, respectively, 
using the AMAXA Biosystems nucleofection procedure. The transfected cell 
monolayers were scratched and stimulated with 1 µM S1P for 20 h. Number of cells 
moved into wound region was quantified and the result is shown in Fig. 25.  
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Figure 25. Effect of overexpression of p110ß KR and p110γ KR mutant on 
S1P-mediated wound healing. 1.0 x 106 HUVEC were transfected with 2 µg of 
p110ß KR (A) or p110γ KR (B) mutant cDNA plasmids, respectively, using the 
AMAXA Biosystems nucleofection procedure. Empty vector pcDNA3 was used 
as a control. 24 h post-transfection a wound region was scratched in the cell 
monolayer. Cells were stimulated with 1 µM S1P and the number of cells 
migrated into the wound was evaluated under microscope. The figure shows 
the mean values ± SEM from five independent experiments. *p < 0.05 versus 
S1P-stimulated control. 
 
 
In agreement with our inhibitor studies, S1P-increased cell movement was 
significantly reduced by p110β KR overexpression, whereas transfection of p110γ 
KR mutant had no effect. These results reveal the essential role of PI3Kβ in 
mediating endothelial cell motility in response to a constant dose of S1P and 
suggest that PI3Kβ may be important during wound repair. In contrast, PI3Kγ was 
not required for S1P-stimulated migration in wound healing assay, although it was 
necessary to mediate endothelial cell chemotaxis.    
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4. Discussion  
 
4. 1 Expression of PI3K in endothelial cells 
 
4.1.1 Expression of PI3K catalytic subunit in endothelial cells 
 
PI3Kβ and PI3Kγ have been demonstrated to be activated by Gi protein. The 
expression of PI3Kβ has been widely detected in mammalian cells, whereas PI3Kγ 
has been thought to be primarily expressed in leukocytes. Consequently, previous 
investigations of PI3Kγ function have been restricted to haematopoietic cells. During 
our current work, however, one group demonstrated that p110γ also exists in HUVEC 
and the END3.1b endothelial cell line and is required for neutrophil capturing and 
rolling by regulating selectin expression (Puri et al., 2005). Additionally, Frey et al. 
have shown more recently that p110γ is expressed in MLEC and regulates NADPH 
oxidase-dependent oxidant production (Frey et al., 2006).  
Our data proved the existence of p110β and γ isoforms at the protein level in HUVEC 
and in primary MLEC and revealed a new functional role of both isoforms in 
endothelial migration (see below). Previous investigations in p110γ knockout animals 
have shown the importance of PI3Kγ in many cell responses. For example, p110γ-/- 
deficiency resulted in a lower level of directed migration in neutrophils and mast cells 
(Hirsch et al., 2000; Sasaki et al., 2000). Furthermore, the superoxide generation was 
defective in p110γ-/- neutrophils which were stimulated by the GPCR-coupled 
chemokine (Li et al., 2000). In these studies, an essential role of p110γ was 
demonstrated that was unable to be substituted by other PI3K isoforms although 
p110β may also be activated by Gi protein. In agreement, we observed differences in 
endothelial cell functional behaviour between wild type and PI3Kγ knockout MLEC 
although a similar protein level of p110β was found in both cell types. Our data also 
indicate that the lack of p110γ does not alter the expression of p110β in MLEC. The 
same result was found in PI3Kγ-/- neutrophils, macrophages and splenocytes which 
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exhibited the same protein level of the PI3Kβ isoform as wild type cells (Hirsch et al., 
2000). 
 
4.1.2 Expression of PI3Kγ regulatory subunit in endothelial cells 
 
Different from PI3K class IA, class IB PI3Kγ has been demonstated to associate with a 
101 kDa adaptor protein, p101. To date, endogenous p101 has been found in U937 
cells (a human monocyte lymphoma cell line), HepG2 cells (a hepatoma cell line), 
VSMC and leukocytes (Stephens et al., 1997; Metjian et al., 1999; Kaplan- 
Albuquerque et al., 2003; Suire et al., 2005). These findings, together with the fact 
that PI3Kγ regulates endothelial cell response, led us to explore whether this p101 
subunit exists in endothelial cells. Interestingly, no p101 messenger RNA was 
observed in HUVEC using RT-PCR technique, although these cells express p110γ at 
both mRNA and protein level. In contrast, we detected p101 mRNA in either wild type 
or p110γ knockout mouse endothelial cells.  
Initially, p101 has been termed as an “adaptor” protein, since it was able to associate 
with and regulate the binding of p110γ and Gβγ subunits in response to G-protein 
coupled receptors (Stephens et al., 1997; Krugmann et al., 1999). Furthermore, 
studies from our group illustrated the requirement of p101 for the PI3Kγ-dependent 
activation of JNK (Lopez-Ilasaca et al., 1998), while Maier has pointed out that p101 
influences the lipid substrate preference of PI3Kγ and its binding protects p110γ from 
degradation (Maier et al., 1999). Nevertheless, some groups have detected PI3Kγ 
activation in the absence of p101, rendering the role of this adaptor protein is still 
controversial. In agreement, our data show that the p110γ catalytic subunit is 
functional and physiologically important in human endothelial cells without the 
assistance of the p101 adaptor protein. The variations between these findings 
probably result from difference in cell types. Additionally, the lack of p101 expression 
in human endothelial cells may point to other adaptor/regulatory subunits interacting 
with p110γ in human endothelial cells.    
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More recently, another non-catalytic subunit of p110γ, p87, was discovered and 
proved to bind to both p110γ and Gβγ subunits and to mediate PI3Kγ activation (Voigt 
et al., 2006). This report prompted us to hypothesise that p87 in HUVEC, instead of 
p101, regulates the function of PI3Kγ. Surprisingly, HUVEC did not display the 
expression of p87 mRNA. Thus, in HUVEC the PI3Kγ catalytic subunit is able to exist 
and function in the absence of p101 or p87 regulatory subunits. Unlike human 
endothelial cells, MLEC isolated from both wild type and p110γ knockout mice 
revealed the expression of both p101 and p87 mRNA. Interestingly, the expression 
level of both adaptors was not affected by the absence or presence of PI3Kγ. In 
contrast, Voigt et al. have demonstrated that in the absence of p110γ, p101 showed a 
lower stability than p87 (Voigt et al., 2006), whereas a reduction of both p101 and p87 
expression was observed in p110γ-negative neutrophils (Suire et al., 2005). The 
presence of p101 and p87 in the same cell has been shown before (Suire et al 2005) 
suggesting that they contribute to different properties of p110γ protein. However, more 
studies are required to understand the function of these adaptors in murine 
endothelial cells. 
In conclusion, our findings suggest that p101 or p87 is dispensable for the function of 
p110γ catalytic subunit in human endothelial cells, since p110γ activation was 
detected in HUVEC lacking the expressions of both regulatory subunits. On the other 
hand, MLEC express both adaptors and their impact on p110γ function should be 
further clarified.  
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4. 2 PI3K-dependent protein phosphorylation/activation in endothelial 
cells  
 
4.2.1 S1P-stimulated Akt phosphorylation and its involvement in 
endothelial migration 
 
Akt, a critical downstream substrate of PI3Ks, has been shown to control abundant 
cellular responses. Upon extracellular stimulation, Akt translocates to the plasma 
membrane via binding to PI(3,4,5)P3, where it becomes activated. S1P has previously 
been demonstrated to trigger this process. In agreement, our studies also show that 
stimulation of HUVEC with S1P results in a rapid and reversible increase of Akt 
phosphorylation. Furthermore, we confirm that Gi protein and PI3K activity are 
involved in S1P-induced Akt activation, since pretreatment of cells with the Gi protein 
inhibitor PTX or the PI3K inhibitor wortmannin completely inhibited Akt 
phosphorylation.  
Gi protein has been shown to activate both PI3Kβ and PI3Kγ via its βγ subunits, 
raising the hypothesis that both is forms are able to mediate Akt phosphorylation in 
S1P-stimulated cells. However, our data indicate that only PI3Kβ is responsible for 
S1P-induced Akt phosphorylation, since TGX-221, the PI3Kβ-specific inhibitor, was 
able to abolish S1P-induced Akt phosphorylation, whereas the PI3Kγ inhibitor 
AS-252424 had no effect. In addition, Akt phosphorylation was unaltered in p110γ-/- 
MLEC. Thus, we show here for the first time that S1P stimulates Akt phosphorylation 
in endothelial cells in a Gi protein-dependent and PI3Kβ-specific manner. 
Consistent with our findings, Igarashi et al. have previously reported that S1P leads to 
a rapid and isoform-specific activation of immonoprecipitated PI3Kβ in BAEC that do 
not express PI3Kγ.  Furthermore, S1P-triggered Akt phosphorylation was abolished by 
wortmannin in this cell type (Igarashi et al., 2001a; Igarashi and Michel, 2001b). Our 
results are in agreement with previous reports showing that the expression of PI3Kβ in 
murine fibroblasts is necessary and sufficient to transmit signals from G-protein 
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coupled receptors to Akt (Murga 2000). However, although our investigations suggest 
that S1P activates Akt in HUVEC and MLEC solely through a Gi/PI3Kβ-dependent 
pathway, the underlying mechanism is still unknown. Full Akt activity depends on its 
translocation from cytosol to the plasma membrane where it becomes phosphorylated 
at its amino acid residues threonine 308 and serine 473. This process may not only be 
dependent on binding of Akt to PI(3,4,5)P3 but may additionally require the p85 
regulatory subunit which is binding only to PI3Kβ but not to PI3Kγ. However, further 
studies are needed to clarify a possible role of the p85 subunit. 
Akt has been demonstrated to be a key effector to regulate cell migration. It has been 
reported that Akt translocates to the plasma membrane and colocalises with F-actin at 
the leading edge of cells in response to a chemoattractant gradient (Servant et al., 
2000; Hannigan et al., 2002). To understand the role of PI3Kβ-mediated Akt activation 
in S1P-induced cell migration, we investigated the effect of TGX-221 which 
completely abolished phosphorylation of Akt. We found that TGX-221-treated cells 
show a 30 % to 40 % inhibited capability to migrate to an S1P gradient or to respond 
in wound healing assays suggesting that the PI3Kβ/Akt-dependent signalling pathway 
may play a role in S1P-stimulated cell motility in HUVEC and other pathways may 
exist.  
In agreement with our studies, it has been revealed that overexpression of a dominant 
negative Akt mutant markedly inhibited S1P-mediated migration in Chinese hamster 
ovary (CHO) –K1 cells transfected with S1P receptor S1P1, whereas this Akt mutant 
had no effect on migration of CHO cells which were transfected with another S1P 
receptor, S1P3 (Lee et al., 2001). On the other hand, S1P1-independent pathways 
exist in endothelial cells which may not signal via Akt. Inoki et al. have mentioned that 
S1P-stimulated migration was S1P3/Gi-dependent in a murine endothelial cell line, 
SVEC4-10, which expresses S1P2 and S1P3, but not S1P1 (Inoki et al., 2006). This 
may explain the wortmannin and TGX-221-insensitive part of S1P-stimulated cell 
movement. Moreover, S1P-induced Akt activation through S1P1/Gi/PI3Kβ may not 
only be involved in cell motility, but also in other cellular responses, for instance in the 
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regulation of endothelial barrier integrity (Lee et al., 2006). Thus, we propose that the 
S1P1/Gi/PI3Kβ signalling pathway is important for S1P-stimulated Akt activation and 
that Akt activity is essentially but not solely responsible for endothelial cell motility 
upon S1P stimulation. 
 
4.2.2 S1P-stimulated eNOS phosphorylation and its involvement in 
endothelial migration 
 
eNOS is known to be a downstream effector of Akt and contributes to endothelial cell 
migration in response to growth factors. In the present study, we show that S1P 
promoted eNOS phosphorylation at the serine 1177 residue in both HUVEC and 
MLEC. Our data reveal that Akt/PI3Kβ is involved in this process since eNOS 
phosphorylation was inhibited by TGX-221 but not by the PI3Kγ-specific inhibitor 
AS-252424. Moreover, our studies in murine endothelial cells display that S1P is able 
to phosphorylate eNOS in wild type as well as in p110γ-/- cells and that the absence of 
this enzyme did not decrease S1P-induced eNOS phosphorylation at serine 1177. 
Thus we conclude that PI3Kγ does not contribute to S1P-induced eNOS activation. 
Neither PI3K inhibition with wortmannin nor PI3Kβ inhibition with TGX-221, however, 
was able to inhibit eNOS phosphorylation completely although Akt phosphorylation 
was blocked under these conditions suggesting that other signalling pathways were 
involved. 
Previous observations have demonstrated that wound healing and angiogenesis was 
impaired in eNOS-deficient mice and that eNOS is required for proper endothelial cell 
migration, proliferation, and differentiation (Lee PC. et al., 1999). Interestingly, an 
involvement of NO in endothelial cells has mainly been attributed to growth factors 
(Dimmeler et al., 2000), whereas conflicting data exist concerning the role of NO in 
S1P-stimulated endothelial cell migration. Morales-Ruiz et al. have provided evidence 
that L-NAME inhibits VEGF-promoted but not S1P-stimulated migration in BAEC 
(Morales-Ruiz et al., 2001), while others showed that the eNOS inhibitor L-NAME 
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suppressed directional cell motility to an S1P gradient (Rikitake et al., 2002; Murohara 
et al., 1999), although the inhibition was lower than 20 %. In the present study, we 
failed to demonstrate an eNOS-dependent migration in response to S1P stimulation, 
since the pretreatment of cells with L-NAME was unable to affect cell movement.  
Taken together, our data suppose that S1P-induced endothelial cell migration is 
independent from eNOS, although S1P is able to induce eNOS phosphorylation via Gi 
protein and PI3Kβ as well as via other pathways. Instead, eNOS may play a more 
important role in growth factor-regulated endothelial cell motility.  
 
4.2.3 S1P-stimulated Rac activation  
 
The Rho family small GTPase Rac regulates actin rearrangement and cytoskeleton 
remodeling such as the formation of ruffles and lamellipodia, thereby being a critical 
effector in cell migration. A previous investigation has shown that S1P stimulates Rac 
activation in endothelial cells, which in turn influences cell motility (Li et al., 2005). 
However, the underlying mechanism was not well characterised. In the present study, 
we demonstrated S1P-induced Rac1 activation in HUVEC and MLEC in a time- and 
concentration-dependent manner which was PTX-sensitive, suggesting the 
requirement of Gi protein. This is consistent with a previous study (Mehta et al., 2005). 
Similarly, the inhibition of the Gi protein-coupled receptor S1P1 has been shown to 
attenuate S1P-induced Rac1 activation in HUVEC (Paik et al., 2001). PI3Ks are 
important downstream effectors of Gi protein and both PI3K and Rac have been 
shown to be involved in regulating S1P-induced endothelial cell migration. 
Accordingly, abrogation of PI3K by a general inhibitor, LY294002, reduced Rac1 
activition upon S1P in human pulmonary artery endothelial cells (Singleton et al., 
2005). In agreement, our findings illustrate that S1P-induced Rac1 activation is 
PI3K-dependent, since pretreatment of cells with wortmannin was able, at least in part, 
to inhibit the level of S1P-activated Rac. In contrast, another group failed to observe 
this response in BAEC (Gonzales et al., 2006), indicating that cell type specificity may 
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influence this process.  
It has been demonstrated that stimulation of macrophages with the cytokines, 
RANTES (regulated on activation normal T cell expressed and secreted) or CSF-1 
(colony-stimulating factor), which couple to GPCR or RTK, respectively, lead to a 
rapid and transient PI3K-dependent Rac activation (Weiss-Haljiti et al., 2004). This 
finding points to a possibility to activate Rac via different PI3K isoforms. Interestingly, 
our results demonstrate a significant decrease of S1P-stimulated Rac1 activation in 
HUVEC and wild type MLEC when cells were pretreated with either TGX-221 or 
AS-252424. Moreover, MLEC lacking p110γ showed a notable decrease of 
S1P-induced Rac activation, which was further downregulated by pretreatment with 
TGX-221. Thus, we suggest that both PI3Kβ and PI3Kγ are important for S1P-induced 
Rac activity.  
S1P stimulates a wide range of cellular responses via the PI3K/Akt pathway. Several 
interactions exist between Akt and Rac1 which seem to be very complex and so far, 
incompletely understood. Akt has been demonstrated to be an upstream effector of 
Rac1 that plays both negative and positive roles. One group showed that Akt reduced 
Rac1 activity by phosphorylating Rac1 at the serine 71 residue and by inhibiting its 
GTP-binding activity in a human melanoma cell line, SK-MEL28 (Kwon et al., 2000). 
In contrast, Lee et al. have demonstrated that in CHO cells stably transfected with the 
S1P1 cDNA sequence, Akt associates with and directly phosphorylates S1P1 at 
threonine 236 upon S1P stimulation which in turn was responsible for Rac1 activation. 
Overexpression of a kinase dead mutant of Akt in these cells led to a full abrogation of 
S1P-mediated Rac1 activation (Lee et al., 2001). On the other hand, Akt was also 
suggested to be downstream of Rac1. The transfection of a constitutively active Rac1 
markedly elicited Akt activity, while knockdown of Rac1 by a specific siRNA entirely 
abolished S1P-stimulated Akt phosphorylation (Genot et al., 2000; Gonzalez et al., 
2006). Interestingly, the membrane translocation of Akt via its PH domain appears to 
be essential for Akt activation by active state Rac (Wang et al., 2002). In the current 
study, S1P-triggered Akt activation was completely inhibited by PI3K inhibitors 
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wortmannin and TGX-221, while these inhibitors only partially reduced Rac1 activity. 
Taken together, we suggest an involvement of Akt in S1P-induced Rac activation 
upon S1P/GPCR/PI3Kβ signalling pathway in endothelial cells, but Rac1 may be also 
activated by Akt-independent signalling molecules in response to S1P stimulation. 
Rac activity was also diminished in HUVEC pretreated with a PI3Kγ-specific inhibitor 
or in p110γ-/- MLEC, whereas in both situations Akt phosphorylation was unaltered. 
This result illustrates that PI3Kγ-dependent Rac activation in response to S1P 
occurred in an Akt-independent manner. Therefore, the interesting question remains, 
through which signalling pathways PI3Kγ may regulate Rac activity. One possibility is 
the involvement of PI3Kγ in the regulation of GEFs such as Vav, Tiam, SWAP-70 and 
P-Rex families. It has been shown, for example, that expression of an inactive mutant 
of PI3Kγ blocked Rac-dependent actin rearrangement in fMLP-stimulated COS-7 cells 
(Ma et al., 1998). Furthermore, the generation of PI(3,4,5)P3 in response to PI3K 
activation enhanced Vav activity (Han et al., 1998). Recently, Li et al. have reported 
that co-expression of the GEF P-Rex2b with Gβγ subunits in HEK293 cells, increased 
Rac1 activation, which was further enhanced by co-expression of P-Rex2b, Gβγ and 
PI3Kγ or a constitutively active mutant of PI3K. Moreover, suppression of endogenous 
P-Rex2b by siRNA significantly inhibited Rac1 activation and cell migration in 
S1P-stimulated HUVEC (Li et al., 2005), indicating that P-Rex2b is partially required 
for S1P-induced Rac1 activation and endothelial migration via a Gβγ/PI3Kγ signalling 
pathway. Recently, another Rac-GEF SWAP70 has been demonstrated to bind 
specifically to PI(3,4,5)P3 and move to membrane ruffles upon growth factor stimulation 
(Shinohara et al., 2002). Furthermore, it was found to bind to activated Rac and 
colocalise with F-actin thereby regulating actin rearrangement. Accordingly, growth 
factor-induced Rac activity, membrane ruffle formation and cell migration were 
impaired in SWAP70-/- cells or in cells that expressing a dominant negative mutant of 
SWAP70 (Shinohara et al., 2002; Ihara et al., 2006; Sivalenka et al., 2004). Finally it 
should be noted that Tiam1 has been shown to be a possible candidate in 
S1P-mediated Rac activation (Singleton 2005, Gonzalez 2006). 
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In summary, our study demonstrates that both PI3Kβ and PI3Kγ are involved in 
S1P-induced Rac1 activation in HUVEC and MLEC. We suggest that these two 
isoforms may influence Rac activation through, at least in part, distinct signalling 
pathways. The individual effect of distinct PI3K isoforms may vary dependent on the 
different stimuli and cell types. Finally, it should also be noted that we observed a 
PTX-sensitive but PI3K-independent part of Rac activation, indicating that some 
additional Gi-mediated signalling pathways are involved in Rac activation in 
S1P-stimulated endothelial cells.   
 
 
4. 3 PI3K-dependency of S1P-induced endothelial cell motility  
 
4.3.1 S1P-stimulated directional endothelial cell migration  
 
When cells are exposed to a chemoattractant agent, they exhibit the ability to move 
into the direction of the gradient. S1P has been demonstrated to be one of potent 
stimuli of cell motility in many cell types, including fibroblasts, smooth muscle cells, 
neutrophils and myoblasts. In most cases, PI3K activation has been found to be 
involved. The PI3K-regulated directional cell movement involves (1) the sensing of a 
chemokine, (2) the recruitment of PH domain-containing proteins at the plasma 
membrane via interaction with PI(3,4,5)P3 generated by PI3Ks, (3) the differential 
polymerisation of F-actin at the leading edge resulting in a defined cell polarity, (4) the 
new adhesion at the front of the cell and (5) the sequential contraction of the body and 
rear of the cell. Cell migration is a fundamental process that contributes to diverse 
biological responses. For example, the directed migration of polymorphonuclear 
leukocytes and macrophages is a critical process in inflammation (Devreotes and 
Zigmond, 1988; Downey et al., 1994). PI3Kγ seems to be dispensable for controlling 
the direction of cell movement. Indeed, it has been dubbed the compass of 
neutrophils (Rickert et al., 2000). Several groups have reported that the production of 
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PI(3,4,5)P3 and cell chemotaxis induced by chemokines such as IL-8, fMLP, and C5a 
were impaired in p110γ gene-deficient murine neutrophils (Sasaki et al., 2000; Li et al., 
2000; Hannigan et al., 2002). Similar results have been found in p110γ-/- dendritic cells 
and macrophages as well as in human melanoma cells transfected with an inactive 
mutant of PI3Kγ (Prete et al., 2004; Hirsch et al., 2000; Lee et al., 2002). So far, it is 
not known, however, which PI3K isoforms mediate migration and whether PI3Kγ plays 
a similar role in endothelial cells as in neutrophils.  
In the present study, we first explored the role of PI3K isoforms in S1P-induced cell 
motility in HUVEC and MLEC. Endothelial cells were exposed to an S1P gradient after 
pretreatment with PI3K isoform-specific inhibitors or transfection with kinase dead 
mutants of PI3Ks, respectively. Our results show for the first time that PI3Kγ is, at 
least in part, responsible for human and murine endothelial cell movement towards an 
S1P gradient since S1P-induced transwell migration was inhibited by the 
PI3Kγ-specific inhibitor AS-252424 or by overexpression of the p110γ KR mutant. This 
conclusion is further supported by showing impaired migration towards S1P in 
p110γ-deficient MLEC. In addition, our data show for the first time that PI3Kβ 
contributes to endothelial cell migration, since HUVEC pretreated with TGX-221 or 
transfected with the p110β KR mutant also revealed a decreased migratory response 
towards S1P. Moreover, TGX-221 was able to further inhibit migration in p110γ-/- 
MLEC. In agreement with these findings, one group has reported that microinjection 
of a PI3Kβ-specific antibody significantly reduced lamellipodia extension and cell 
migration in macrophages (Vanhaesebroeck et al., 1999b). Our data suggest that 
both PI3K isoforms are necessary to mediate endothelial cell migration in response to 
an S1P gradient, the underlying mechanism are, however, not well understood.  
The product of PI3K lipid kinase activity, PI(3,4,5)P3, has been indicated to be an 
important player in the regulation of cell polarity by generating an intracellular gradient 
necessary for polarised signalling and cell movement. Our results suggest the 
possibility that both PI3Kβ and PI3Kγ activation in endothelial cells may be essential 
for S1P-mediated PI(3,4,5)P3 generation although in neutrophils PI3Kγ has been 
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demonstrated to be the major isoform responsible for fMLP-induced PI(3,4,5)P3 
production (Wu et al., 2000). Recent studies have demonstrated the indispensability 
of PI3K class IA for chemokine-increased PI(3,4,5)P3 level (Boulven et al., 2006; 
Condliffe et al., 2005). On the other hand, different PI3K isoforms may have distinct 
effects on signalling molecules such as Akt or Rac that have been known to be 
essential regulators of cell motility. As discussed above, Akt translocates to the 
leading edge of cells in response to a chemoattractant to trigger cell migration (Parent 
et al., 1998; Servant et al., 2000), while cells lacking Akt are unable to properly 
polarise when placed into a chemotactic gradient (Chung and Firtel, 2002). In addition, 
the importance of Rac and Akt in regulating directed cell migration was confirmed by a 
significantly diminished formation of lamellipodia and cell motility in endothelial cells 
transfected with inactive mutants of Akt or Rac (Lee et al., 2001; Lee et al., 2006). 
Since S1P-stimulated Akt phosphorylation at serine 473 residue can be totally 
blocked by a PI3Kβ-specific inhibitor, we hypothesise that PI3Kβ may primarily 
transmit the signal via the downstream effector Akt further leading to Akt-dependent 
Rac activation or to activation of other Akt-dependent pathways. In addition, PI3Kβ 
may activate Rac-GEFs directly. PI3Kγ may probably mainly function through 
activation of the small GTPase Rac via GEFs and may be especially important for 
actin reorganisation at the leading edge (Fig. 26). It should also be noted, however, 
that S1P-induced migration was not completely reduced by wortmannin or the 
combination of PI3Kβ and PI3Kγ inhibitors, indicating the existence of other Gi 
protein-dependent signalling pathways.  
 
4.3.2 S1P-stimulated endothelial cell migration in wound healing 
 
When tissues are injured in living organisms, the endothelium contributes partially to 
wound healing by increasing proliferation and angiogenesis. S1P generated upon 
platelet activation may participate in wound healing as a mediator of this process. 
Therefore, the motility of HUVEC was further evaluated in vitro by a wound healing 
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assay. In contrast to migration towards a chemotactic gradient, the wound healing 
assay investigates cell movement in the presence of a constant dose of the 
chemoattractant. Previous studies have already shown that S1P increased motility in 
wound healing assays in HUVEC and BAEC (Lee et al., 2000). 
Our results demonstrate that S1P-induced HUVEC wound healing was significantly 
reduced by impairment of PI3Kβ with either an isoform-specific inhibitor or a dominant 
negative mutant. On the contrary, inhibition of PI3Kγ showed no effect on 
S1P-induced cell movement into the wound region. Our data demonstrate for the first 
time that migration of endothelial cells in the absence of a chemoattractant gradient 
requires only PI3Kβ but not PI3Kγ activation. These data are in agreement with 
findings from fMLP-stimulated p110γ-/- neutrophils showing that only cell chemotaxis 
was decreased in these cells whereas chemokinesis was not impaired (Hannigan et al. 
2001). In this study, it was demonstrated that the lack of directionality likely results 
from a defect in the ability to stabilise and consolidate a leading edge. The authors 
postulate that in fMLP-stimulated neutrophils the function of PI3Kγ is to produce 
PI(3,4,5)P3 at the leading edge which would recruit PH domain containing proteins to the 
cell membrane of the leading edge and in turn cause the redistribution of F-actin and 
other relevant proteins to provide the directionality for cell movement. Similar 
mechanisms could play a role in endothelial cells responding to a chemotactic 
gradient. In contrast, the role of PI3Kγ may be dispensable for the control of the speed 
of migration and PI3Kβ may have a major role in the regulation of random migration. 
In agreement with this hypothesis, the overexpression of a dominant negative mutant 
of p85, the regulatory subunit of PI3K class IA, resulted in a notable decrease of 
S1P-induced cell migration into the wounded area of a BAEC monolayer (Rikitake et 
al., 2002), pointing to a role of PI3Kβ in this process. Akt may be one of the PI3Kβ 
downstream effectors responsible for the regulation of chemokinesis, since cells 
lacking Akt move slowly (Chung and Firtel, 2002). Moreover, transfection of HUVEC 
or BAEC with dominant negative Akt significantly attenuated wound healing upon S1P 
stimulation (Lee et al., 2006; Rikitake et al., 2002). In addition, our data revealed 
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PI3Kβ as the only PI3K isoform signalling through Akt suggesting that Akt is involved 
in PI3Kβ-mediated random migration. Since PI3Kβ inhibition also diminished Rac 
activation, Rac may also contribute to cell migration in wound healing assays. 
Overexpression of an inactive form of Rac1 in neutrophils resulted in an inefficient 
“tail” retraction at the backward side of cells (Pestonjamasp et al., 2006). 
In conclusion, our study suggests that a chemotactic S1P gradient is able to increase 
endothelial cell motility through Gi-mediated PI3K activation. Different isoforms, PI3Kβ 
and PI3Kγ, which are known to be activated by Gi protein βγ subunits, are essential to 
mediate the directional cell movement. On the contrary, our results show that only 
PI3Kβ is required for the S1P-mediated endothelial migration in wound healing assays. 
Moreover, S1P stimulation leads to Akt phosphorylation only via PI3Kβ, whereas 
S1P-induced Rac activation is dependent on both PI3Kβ and PI3Kγ activities.  
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Figure 26. Model for the involvement of PI3Kβ and PI3Kγ isoforms in 
S1P-induced endothelial cell migration. The model suggests a hypothesis 
that S1P is able to stimulate endothelial cell migration through both PI3Kβ and 
PI3Kγ pathways. PI3Kβ may primarily transmit the signal via the downstream 
effector Akt further leading to Akt-dependent activation of small GTPase Rac. 
In addition, PI3Kβ may activate Rac-GEFs directly. PI3Kγ may mainly function 
through activation of Rac via GEFs and may be especially important for actin 
reorganisation at the leading edge. Furthermore, both PI3K isoforms may 
amplify each other via their downstream effectors. 
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Zusammenfassung 
 
Phosphoinositid-3-Kinasen (PI3-Kinasen) spielen in vielen zellulären Prozessen wie 
Proliferation, Inflammation und Migration eine zentrale Rolle. Die beiden Isoformen 
PI3-Kinase γ und β werden nach Stimulierung von Gi-Protein-gekoppelten Rezeptoren 
durch verschiedene Agonisten aktiviert und sind in die Regulation der Zellmotilität 
einbezogen. PI3-Kinase γ ist beispielsweise ein Schlüsselmediator bei der durch 
Chemokine stimulierten Migration von Leukozyten. PI3-Kinasen beeinflussen die 
Zellmigration vor allem über die Proteinkinase Akt und verschiedene 
Guanin-Nukleotid-Austausch-Faktoren (GEFs), die zur Aktivierung der kleinen 
GTPase Rac führen. 
Sphingosin-1-phosphat (S1P), ein wirkungsvoller Angiogenesefaktor, aktiviert 
PI3-Kinasen, Akt und Rac in Endothelzellen über seinen an Gi-Proteine gekoppelten 
Rezeptor S1P1 und reguliert auf diese Weise die Migration von Endothelzellen. Bisher 
ist kaum bekannt, welche PI3-Kinase-Isoformen durch S1P stimuliert werden und die 
S1P-induzierte Migration von Endothelzellen vermitteln. In der vorliegenden Arbeit 
wurde daher die Rolle der PI3-Kinase-Isoformen γ und β in der S1P-induzierten 
Signaltransduktion und Migration in humanen Nabelschnur-Endothelzellen (HUVEC) 
und in murinen mikrovaskulären Lungen-Endothelzellen (MLEC) untersucht. 
Unsere Daten zeigen, dass die katalytischen Untereinheiten von PI3-Kinase γ  und β 
in HUVEC und MLEC exprimiert sind. Im Gegensatz dazu konnte die mRNA der 
regulatorischen Untereinheiten der PI3-Kinase γ, p101 und p87PIKAP, nur in MLEC, 
nicht aber in HUVEC nachgewiesen werden. Dieser Befund lässt vermuten, dass 
PI3-Kinase γ auch ohne diese Adapterproteine funktionsfähig ist. 
Um die Rolle der beiden PI3-Kinase-Isoformen zu charakterisieren, wurde die Aktivität  
von PI3-Kinase β  oder PI3-Kinase γ mit spezifischen Inhibitoren (TGX-221 für 
PI3-Kinase β, AS-252424 für PI3-Kinase γ) oder durch Überexpression der 
dominant-negativen Mutanten p110β-KR oder p110γ-KR inhibiert. Außerdem wurden 
Experimente in MLEC aus PI3-Kinase-γ-Knockout-Mäusen (p110γ-/-) durchgeführt. 
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Unsere Ergebnisse bestätigen, dass S1P sowohl die Phosphorylierung von Akt und 
seines nachgeschalteten Effektors, der endothelialen NO-Synthase (eNOS), induziert 
als auch die Aktivierung von Rac stimuliert. Diese Prozesse waren 
PI3-Kinase-abhängig, da sie durch den PI3-Kinase-Inhibitor Wortmannin gehemmt 
wurden. Interessanterweise wurde die S1P-stimulierte Akt-Phosphorylierung 
vollständig und die eNOS-Phosphorylierung teilweise durch PI3-Kinase β vermittelt, 
während die Inhibition von PI3-Kinase γ keinen Einfluss auf den Akt/eNOS-Signalweg 
hatte. Im Gegensatz dazu wurde die durch S1P induzierte Rac-Aktivität sowohl durch 
Inhibition der PI3-Kinase β (TGX-221) als auch Inhibition der PI3-Kinase γ 
(AS-252424) verringert. Diese Daten zeigen daher, dass beide Isoformen an der 
durch S1P induzierten Rac-Aktivierung beteiligt sind. Dementsprechend war die 
Rac-Aktivierung durch S1P in p110γ-/--MLEC ebenfalls vermindert. 
Zur Untersuchung der S1P-induzierten Migration wurden Transwell-Migrationsassays 
und Wound-Healing-Assays durchgeführt. Unsere Ergebnisse bestätigen, dass S1P 
die Migration von HUVEC und MLEC über Gi-Protein- und PI3-Kinase-abhängige 
Signalwege auslöst, da sie durch Pertussis-Toxin, einen Gi/o-Protein-Inhibitor, oder 
Wortmannin gehemmt wurden. Im Transwell-Assay, bei dem die Bewegung der 
Zellen in Richtung eines S1P-Gradienten untersucht wurde, führte sowohl die 
Hemmung der PI3-Kinase β als auch die der PI3-Kinase γ zu einer signifikanten 
Reduktion der Migration. Ein ähnliches Ergebnis hatte die Expression der 
dominant-negativen Mutanten beider Isoformen. Auch p110γ-/--MLEC wiesen eine 
verminderte Fähigkeit auf, sich entlang des S1P-Gradienten zu bewegen, und diese 
bereits reduzierte Reaktion wurde durch Inhibition der PI3-Kinase β noch weiter 
verringert. Im Gegensatz dazu scheint die Migration im Wound-Healing-Assay, die 
durch eine konstante Dosis von S1P induziert wird, nur von der Aktivierung der 
PI3-Kinase β abzuhängen. Unsere Daten zeigen, dass lediglich die Inhibition von 
PI3-Kinase β, aber nicht von PI3-Kinase γ, in der Lage war, diesen Prozess zu 
beeinträchtigen. Diese Ergebnisse lassen uns schlussfolgern, dass sowohl 
PI3-Kinase β als auch PI3-Kinase γ für die gerichtete Zellbewegung benötigt werden, 
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während die Migration ohne chemischen Gradienten nur PI3-Kinase β erfordert. Eine 
mögliche Funktion der PI3-Kinase γ könnte darin bestehen, die Zellfront („leading 
edge“) durch lokale Produktion von PI(3,4,5)P3 zu stabilisieren. Wie bereits in 
Neutrophilen beschrieben wurde, könnte das zu einer lokalen Rekrutierung von 
Proteinen mit PH-Domäne und Polymerisation von F-Aktin führen.  
Wir vermuten, dass die beiden untersuchten PI3-Kinase-Isoformen unterschiedliche 
Signalwege steuern, wobei Akt der Haupteffektor von PI3-Kinase β ist und Rac einen 
nachgeschalteten Mediator beider PI3-Kinasen darstellt. Möglicherweise werden 
unterschiedliche Rac-GEF-Proteine von PI3-Kinase β und γ aktiviert. Unsere 
Ergebnisse gewähren neue Einblicke in die Regulation der Migration von 
Endothelzellen, welche einen essentiellen Prozess der Angiogenese darstellt. 
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Summary  
 
Phosphoinositide 3-kinases (PI3Ks) have been indicated to play a central role in many 
cellular processes, such as proliferation, inflammation and migration. Two isoforms, 
PI3Kβ and PI3Kγ, are known to be activated by Gi proteins in response to different 
stimuli and to regulate cell motility. For instance, PI3Kγ has been demonstrated to be 
a key mediator in chemoattractant-stimulated leukocyte migration. Downstream 
mediators of PI3Ks involved in cell migration include the protein kinase Akt and 
guanine nucleotide exchange factors (GEFs) which lead to the activation of the small 
GTPase Rac.  
Sphingosine 1-phosphate (S1P), a potent angiogenic factor, is known to activate 
PI3Ks , Akt and Rac in endothelial cells via its Gi protein-coupled receptor S1P1 and to 
regulate endothelial cell migration. However, so far the function of PI3Kβ and PI3Kγ 
isoforms in S1P-induced endothelial migration is poorly understood. In the present 
study, we investigated the role of both PI3K isoforms in S1P-induced signalling and 
migration in human umbilical vein endothelial cells (HUVEC) and in mouse lung 
microvascular endothelial cells (MLEC).  
Our data show that the catalytic subunits of both, PI3Kβ and PI3Kγ, are expressed in 
HUVEC and MLEC at the protein level. In contrast, mRNA of the regulatory subunits 
of PI3Kγ, p101 and p87PIKAP, was only detected in MLEC but not in HUVEC 
suggesting that PI3Kγ can be functional in the absence of these adaptor proteins.  
To characterize the role of PI3K isoforms, we selectively targeted PI3Kβ or PI3Kγ 
activities by pretreating endothelial cells with specific inhibitors (TGX-221 against 
PI3Kβ; AS-252424 against PI3Kγ), or by overexpressing dominant negative mutants 
of PI3Kβ (p110β KR) or PI3Kγ (p110γ KR). Furthermore, we performed studies in 
MLEC derived from PI3Kγ gene knockout (p110γ-/-) mice.  
Our data confirm that S1P stimulates the phosphorylation of Akt and its downstream 
effector endothelial nitric oxide synthase (eNOS) as well as Rac activation in a 
PI3K-dependent way since all parameters were inhibited by wortmannin, a general 
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PI3K inhibitor. Interestingly, only PI3Kβ was responsible for Akt phosphorylation and, 
partially, for eNOS phosphorylation, whereas PI3Kγ inhibition had no effect on the 
Akt/eNOS pathway. In contrast, inhibition of PI3Kβ or PI3Kγ by TGX-221 or 
AS-252424, respectively, attenuated Rac activity in response to S1P stimulation 
indicating that both isoforms are involved in S1P-induced Rac activation. Accordingly, 
Rac activation in response to S1P was diminished in p110γ-/- MLEC.  
To investigate S1P-induced migration, a transwell migration assay and a wound 
healing assay were performed. Our data confirm that S1P induces HUVEC and MLEC 
migration through Gi protein- and PI3K-dependent pathways, since pertussis toxin, a 
Gi/o protein inhibitor, and wortmannin revealed inhibitory effects. In the transwell assay, 
which investigates cell migration towards an S1P gradient, inhibition of both, 
PI3Kβ  and PI3Kγ, resulted in a significant reduction of the migratory response. A 
similar result was observed when dominant negative mutants of both isoforms were 
exploited to inhibit enzyme activities. Moreover, p110γ-/- MLEC displayed less 
capability to move along an S1P gradient which was further reduced by inhibiting 
PI3Kβ in these cells. In contrast, migration in wound healing assays which was 
induced by a constant dose of S1P seems to be only dependent on PI3Kβ activation, 
since only specific targeting of PI3Kβ but not of PI3Kγ was able to impair this process. 
Based on these results, we suggest that both, PI3Kβ and PI3Kγ, are required for 
directional cell movement, whereas migration in the absence of a chemotactic 
gradient requires only PI3Kβ. A possible role of PI3Kγ may be to stabilise the leading 
edge of the cells by local production of PI(3,4,5)P3, which leads to neighboring 
recruitment of PH domain containing proteins and F-actin polymerisation as described 
in neutrophils.  
We suggest that the two PI3K isoforms signal through different pathways with Akt 
being a major effector of PI3Kβ and Rac being a downstream mediator of both 
PI3Ks. We also suggest that different Rac-GEFs may be activated by PI3Kβ or PI3Kγ . 
Our results provide new insights in the regulation of endothelial migration which is an 
essential process in angiogenesis.  
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